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AMPs  Antimicrobial peptides 
AMPB  4-[(4-aminomethyl)phenylazo]benzoic acid 
AMPP  [3-(3-aminomethyl)phenylazo]phenylacetic acid 
Boc  tert-Butoxycarbonyl 
CD  Circular dichroism spectroscopy 
DAETs Diarylethenes 
DIPEA N-N-Di-iso-propylethylamine 
DMEM Dulbecco's modified Eagle's medium 
DMF  Dimethylformamide  
DMPC  1,2-dimyristoyl-sn-glycero-3-phosphocholine 
DMPG 1,2-dimyristoyl-sn-glycero-3-phospho-rac-(1-glycerol) 
DMSO Dimethylsulfoxide 
FBS  Fetal bovine serum 
Fmoc  9-Fluorenylmethyloxycarbonyl 
GS  Gramicidin S 
HBTU  N-[(1H-Benzotriazol-1-yl)(dimethylamino) methylene]-N-
methylmethanaminium hexafluorophosphate N-oxide 
HOBt   1-Hydroxybenzotriazole 
MALDI-TOF Matrix-assisted laser desorption/ionization mass-spectrometry (time-of-flight 
detection) 
MBHA 4-methylbenzhydrylamine 
MIC  Minimum inhibitory concentration 
MTT  Microculture tetrazolium assay 
NMR  Nuclear magnetic resonance spectroscopy 
PB  Phosphate buffer 
PDT  Photodynamic therapy 
POPC  1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine 
POPS  1-palmitoyl-2-oleoyl-sn-glycero-3-phospho-L-serine 
PTT  Photothermal therapy 
PyBOP (Benzotriazol-1-yloxy)tripyrrolidinophosphonium hexafluorophosphate 
P/L  Peptide to lipid ratio (mol/mol) 
RBC  Red blood cells 
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RP-HPLC Reverse-phase high-performance liquid chromat graphy 
RT  Retention time 
SDS  Sodium dodecyl sulfate 
SPPS  Solid-phase peptide synthesis 
TFA  Trifluoroacetic acid 
TLC  Thin layer chromatography 
Tris-HCl 2-Amino-2-(hydroxymethyl)-1,3-propanediol hydrochloride 
UV  Ultraviolet light 







1.1. Operational photocontrol of biological processes 
 
Development of a new pharmacological agent is an extremely time- and effort- 
consuming process: on the way from a lead to a real drug plenty of complications are faced. 
Most often low bioavailability, reduced in tissue drug selectivity, presence of side effects, and 
poor overall biostability are the main “unforeseen” problems encountered in the early in vivo 
translational experiments1,2. Often these problems are attributed to the insufficient 
pharmacokinetics of the pharmaceutical agent, e.g. due to non-specific tissue absorption, 
peculiarities of the distribution, metabolism and excr tion pathways in a particular test 
organism3. For example, most anti-cancer drugs act through the interference with the process 
of cell division during mitosis4. As a result of low selectivity, besides tumor cells, they are 
affecting other fast-dividing pluripotent cells in a living organism5. Another problem of the 
practical drug application is the adaptation of the targeted cells which leads to resistance, like 
most widely discussed rapid development of acquired antibiotic resistance by bacteria6. Due 
to the narrow therapeutic index, antibiotics are often used at the suboptimal concentrations 
allowing and even stimulating bacteria to evolve into resistant variants. Luckily, many of the 
abovementioned problems could be coped with already on the agent design stage if additional 
controllers are built-in as obligatory design elements. 
One of the most attractive ways to achieve such an extra handle is using the concept 
of dynamic photocontrol7,8,9,10,11. This is because light is non-invasive, easily to manipulate 
and orthogonal to most biological stimuli, which potentially allows precise spatial and 
temporal control. Using light for dynamic control of a therapeutic agent is a subject of 
photopharmacology that is actively developing in recent years12. The main applied areas of 
photopharmacology are photodynamic and photothermal therapies, controlled drug and gene 
delivery. 
The photodynamic therapy (PDT) utilizes special molecu es, photosensitizers, which 
under irradiation with light generate active species of oxygen (1O2)
13 or nitric oxide (NO)14. 
The presence of these at illuminated locations causes immediate local cytotoxic effect of high 
temporal efficiency. In the photothermal therapy (PTT) the light is used to heat the tissues in 
the range of 41-47°C for several minutes15. The heating causes irreversible damage of the 
tissues in the light-exposed areas. Addition of exog nous dyes and nanoparticles is used to 
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increase the absorption of light and promote the destructive effect. The PDT and PTT are 
widely used, in particular for the treatment of caner and infectious diseases. 
In the photocontrolled drug delivery approaches the biologically active agent is either 
deactivated by protecting the pharmacophore with a photocleavable group or encapsulated 
into a photoresponsive entrapping material. In the former, the “photocaging” strategy, the 
light stimulus is used to activate systemically administered caged molecules, which can be 
small drugs, proteins, or nucleic acids16,17. Not only time, but also dosage and location can be 
precisely controlled by the intensity and duration f the activating light signal. Though 
typical biological tissues are insufficiently transparent to visual light, the use of the two-
photon excitation, e.g. employing the near-infrared light allows overcoming the problem. The 
photochemical internalization strategy, the “phototrapping”, most often employs 
nanostructures loaded with the biologically active agents, which could change their loading 
capacity such that entrapped material could be releas d upon triggering signal of light. 
Different surface-modified metal nanoparticles18, dendritic and polymeric nanomaterials19, 
vesicles20 and mesoporous silica-based nanoparticles21 have been validated as promising 
photo-traps for in vivo applications. These nanostructures besides carrying the cargo usually 
have better (at least different) pharmacokinetic prope ties than the carried active agent itself. 
For example, they can co-deliver inside the cell moecules which normally cannot cross the 
cell membrane. 
Another large area within current medicinal photopharmacology is the exploitation of 
molecular photoswitches – small organic molecules capable of undergoing reversible 
photoisomerization reactions12. Typically within related structure-function paradigm, specific 
biological effect of a therapeutic agent is manifested through its interaction with a particular 
(mostly proteinous in chemical nature) target, which could be functionally a receptor, an 
enzyme or an ion channel22. The modification of the drug molecule with a photoswitch 
permits easy structure manipulation allowing indirect regulation of its macroscopic 
characteristics such as shape and hydrophobicity and as a result to control its interaction with 
the target.  
The incorporation of molecular photoswitches into peptides or proteins shifts the 
control handle of their structures and functions to the process of switch photoisomerization. 
Here the relative strength of the photoinduced impact (the conformational transition of the 
photoswitch) to the overall size of the modified object (the polypeptide) starts playing 
important role. The switch isomerization could be too week to propagate structural changes to 
the whole polypeptide (if the polypeptide is large) or the switch could be itself too large as an 
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add-on moiety and completely destroy the original peptide function (if the polypeptide is too 
small). Therefore it is crucially important to understand general principles and to investigate 
structural effects of the isomerization process for any novel molecular photoswitch, or a new 
way of the switch installation. In particular, for creating a photoswitchable peptide-modifying 
unit, on the structure and function of model polypeptides, including small peptides12. Such 
studies are not only of a fundamental interest, they also generate new drug leads as various 
bioactive peptides are present in living systems. The chosen objects of the studies can 
themselves become promising targets for modification with molecular switches.  
 
1.2. Molecular photoswitches 
 
In recent years chemically engineered photoswitchable compounds have become more 
and more popular tools for addressing different biological questions and a variety of synthetic 
photoswitches have been designed. Most of the known photochromic systems undergo either 
cis/trans isomerization of a double bond or unimolecular pericyclic reaction (Figure 1.1.).  
Molecular photoswitches are logically classified according to changes that are occurring upon 
photoisomerization. The changes may involve alteration of the geometrical structure, polarity, 
oxidation/reduction potential, fluorescence and other physical properties. In cases of 
azobenzene, stilbene, spiropyran, and hemithioindigo photoswitches the cis/trans 
isomerization occurs during the interaction with light. This results in significant geometric 
and steric alterations as the consequence of the switching process. The azobenzenes and 
spiropyrans are especially useful for reversibly creating the steric bulk11. Essentially different 
situation is observed in diarylethene and fulgide systems where changes in conformational 
flexibility can be generated through switching process, while geometrical changes are usually 
not so large.  
For advantageous biological applications the photoswi ches are required to 
additionally possess other physical properties, such as: (i) being able to undergo sufficiently 
fast photoisomerization, (ii) demonstrating high quantum yields especially at the wavelengths 
nondestructive for living cells, and (iii) exhibiting high fatigue resistance in aqueous 
environments12. Besides, one of the particularly important requirements is a high thermal 
stability of both photoforms. Usually, the photogenerated colored isomers are thermally 
unstable and convert to the initial state without irradiation. Thermally reversible compounds 
(classified as T-type molecular switches, Figure 1.1.a, 1.1.b, 1.1.c) are the majority of known 
photochromic compounds, including azobenzenes and spiropyrans. In contrast, stilbenes, 
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furylfulgides, and diarylethenes (DAETs) with heterocyclic aryl groups belong to the 
thermally irreversible (P-type) photochromic compounds (Figure 1.1.a, 1.1.d, 1.1.e). 
Obviously, last three structures are the most prospective candidates for the development of 
technically applicable photoswitches. 
 
Figure 1.1. Overview of the photoinduced forms for the most studied molecular 
photoswitches: (a) azobenzenes (X=N), stilbenes (X=C); (b) hemithioindigos; (c) 
spiropyrans; (d) diarylethenes; (e) fulgides (Y=O), and fulgimides (Y=N). 
 
1.3. DAETs as promising photoswitches 
 
From the practical perspective of photoswitches application in biological systems 
DAETs are the most promising candidates among P-type photoswitches for several reasons.  
A major drawback of stilbenes is their tendency to undergo irreversible oxidation in the cis 
form23. Furylfulgides and related compounds also possess poor chemical stability24. On the 
contrast, DAETs advantageously differ from stilbenes and furylfulgides in their remarkably 
high fatigue resistance. The cycle of switching between two forms by the alternate irradiation 
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with UV or visible light could be repeated more than 10 000 times without apparent 
chromophore degradation25. Both ring-cyclisation and ring-opening processes occur rapidly 
in the picosecond time scale. These features suggest DAETs as preferable scaffold of the all 
known DAE-based structures for applications in the engineered photocontrolled biological 
processes. 
 
1.3.1. Synthesis of DAETs 
 
Among large number of synthesized and studied DAETs the most commonly used are 
diarylperfluorocyclopentenes25. These compounds can be prepared in a very simple and 
reliable way shown in the Scheme 1.1. Both symmetric and non-symmetric DAETs with 
various heterocyclic aryl groups could be obtained by the reaction of perfluorocyclopentenes 
with aryllithium. The use of the equimolar amounts of the perfluorocyclopentene and 
aryllithium leads to mono-substituted perfluorocyclopentenes which can subsequently be 
applied for the synthesis of non-symmetric DAETs26. 
 
Scheme 1.1. Synthesis of diarylperfluorocyclopentenes through t e reaction of 
perfluorocyclopentene with aryllithium. 
In 2003, Feringa and coworkers proposed an alternative way for synthesis of the 
DAETs possessing a non-fluorinated aliphatic ring27. The synthetic approach is based on the 
acylation of heterocyclic derivatives, followed by a McMurry intramolecular ring-closing 
reaction28. The original example is shown in the Scheme 1.2. The key step is the formation of 
a new ethylene group during cyclisation of the corresponding 1,5-diaryl-1,5-diketone 1 into 
diarylethene 2a. Based on the McMurry coupling, the DAETs with different aryl groups and 





Scheme 1.2. McMurry pathway to dithienylcyclopentenes. 
 
1.3.2. Physical and chemical properties of DAETs 
 
The first example of the thermally irreversible photochromic DAET was reported in 
1988 by Irie et al.29. Since then various types of DAETs having thiophene, i dole, furan, 
thiazole, and selenophene aryl groups have been prepared. Major synthetic developments 
were directed towards increase in the thermal stability of DAETs and their fatigue resistance 
during photochromic reactions.  
Theoretical30 and experimental12 investigations of the DAETs revealed that the thermal 
stability of the closed-ring isomers depends on three main factors: (i) stabilization energy of 
the aromatic groups, (ii) electronic properties of the substituents at the aryl groups, and (iii) 
steric repulsion of the substituents at the reactive carbons.  
 It was shown (factor i), that when aryl groups have low aromatic stabilization energies 
like in the cases of thiophene, furyl, or benzothiop ene groups, the closed-ring isomers 
become thermally stable. At the same time, when aryl groups have high aromatic stabilization 
energies like in the cases of phenyl, indolyl, or py rolyl groups, the closed forms appear 
thermally reversible. Direct correlation between the aromatic stabilization energies of the aryl 
aromatic systems (Table 1.1.) and the thermal stability could be therefore drawn12,30. 
 
Table 1.1. Aromatic stabilization energies for different aromatic systems30 






Introduction of the electron-withdrawing substituents at the aryl group (factor ii) leads 
to decrease the thermal stability of the closed-ring forms. The effect is explained by the 
weakening of the reactive carbon-carbon bonds in the photogenerated closed-ring isomers11. 
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On the other hand, introduction the electron-donating groups stabilizes the formed carbon-
carbon bond in the closed-ring isomers. However, such substitution decreases at the same 
time the oxidation/reduction potential of the DAETs and makes them more sensitive to 
oxidation31. 
Bulky substituents at the reacting positions (factor iii) also have been demonstrated to 
enhance thermal reversibility of the closed-ring isomers23,32. These studies established inverse 
proportional relationship between the thermal stabili y and theoretically calculated bond 
length linking the reactive carbon atoms 24. 
Another important property of the molecular photoswitches is their fatigue resistance – the 
ability to undergo photochromic transformations without destruction. In the photoswitching 
process, interaction of a photochromic compound with light leads to particular rearrangement 
of chemical bonds. However, undesirable side reactions can take place during this process. 
The equation below illustrates the photochromic conversion between compounds A and B 
(quantum yields ΦA

B and  ΦB

A) accompanied by a non-reversible side reaction leading to 
the compound B'  with the quantum yield ΦS. Formation of the side products limits the 
number of possible photochromic cycles. Even if the side reaction quantum yield ΦS is as 
small as, for example, 0.01, 40% of the initial amount of A will be decomposed after 50 
cycles of coloration/decoloration.  
 
The fatigue resistance of several DAET derivatives has been quantitatively 
measured11,33. Selective examples are shown in the Table 1.2.  
From these and similar studies two factors – oxidative stability and nature of 
rearrangements were concluded to determine the photoc romic stability of DAETs. For 
example, compound 3a showed low durability in the presence of oxygen due to endoperoxide 
formation by reaction with the photogenerated singlet oxygen12,38. The stability of this DAET 
increased remarkably when benzothiophenes were substituted for the thiophene rings 
(compound 6a)39. The benzothiophene derivatives were found to have better oxidation 






Table 1.2. Fatigue resistance of DAETs. 
 
*The number of photochromic cycles at which the absorption of the open-ring isomer has decreased to 80%
compared to initial cycle. 
 
In another study, the difference in fatigue resistance of compounds 6a and 7a provided the 
clue for understanding the nature of molecular rearrangements underlying the 
photodestruction30. Compound 7a differ from 6a by additional methyl groups at the 4- and 4'-
positions of the thiophene rings. The absorbance of the colorless form of compound 7a 
remained almost constant during coloration/decolorati n, while the absorbance of 6a 
Compound 
Number of repeatable cycles* 
Reference 














3.7 × 103 
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significantly decreased already after 200 cycles. A photostable violet-colored by-product was 
isolated from the fatigued solution of 6a. The molecular structure of the by-product was 
determined by X-ray crystallographic analysis as a ix-membered fused-ring structure 9 
(Figure 1.2.). It appears that in the oxygen-free environment the rearrangement leading to the 
by-products of this type is the main fatigue degradation process of the dithienylethenes 
lacking substituents at the 4- and 4'-positions of the thiophene ring. 
 
 
Figure 1.2. The by-product formation during fatigue degradation of the DAET molecule with 
free 4-,4'-positions of the thiophene rings. 
 
The overwhelming majority of studied DAETs are diarylperfluorocyclopentenes, 
presumably due to convenience of the synthetic approaches to them30. Besides, the 
perfluorinated five-membered ring, as was demonstrated in the above example, provides the 
DAET molecules with additional oxidative stability during photochromic cycles. 
Corresponding dithienylcyclopentenes generally demonstrated lower fatigue stability 
comparing to the fluorinated counterparts (e.g. comp und 8a)27,37. Therefore, 
dithienylcyclopentene-containing DAETs are inappropriate to be used in photoelectronic 
devices, but they have found broad application in others technologies were the large number 
of switching cycles is not required8. For example, fatigue resistance is not a limitation for 
photoactivated one-step drug releasing systems becaus  their functions are accomplished 
after a single transformation to the active form. Besides, the non-fluorinated DAETs are less 
hydrophobic and their molecules are less bulky comparing to the fluorinated analogues. 
Optical properties of the photoswitches are obviously most critical for any light-
controlled application. Typical changes in the absorpti n spectrum of a DAET derivative 
upon photoisomerization are shown in the Figure 1.3. Typically, the open-ring isomers of 
DAETs have absorption bands at shorter wavelengths than the closed-ring isomers. Most 
DAETs show very large spectral shifts upon photoisomerization. The π-electrons delocalize 
throughout the two fused thiophene rings in the closed-ring isomers and the delocalization 
path extends further to the substituents at the aryl rings. Notably, the maxima in the 
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absorption spectra of the closed-ring isomers strongly depend on the type of substituents at 
the aryl rings41.  
 
 
Figure 1.3. Absorption spectra of DAETs exemplified by the compound 7. Blue line 
corresponds to open-ring form 7a; red line – to the closed-ring form 7b. Adapted from ref. 40. 
 
Photochromic compounds that have the absorbance bands shifted to the “red” region 
(600-830 nm) have been considered more advantageous for the application in optical memory 
media. The use of the long-wavelength light for the photoisomerization is also more 
preferable for bio-applications, mostly due to better tissue penetrating ability of the long-
wave light. In an attempt to develop a near-infrared light-sensitive photochromic DAET 
compounds, the effects of substituents on their absorption maxima was examined. Figure 1.4. 
summarizes typical absorption maxima of the closed-ring isomers25,34,35,42,43,44,45. Most 
important factors that determine the absorption profile for DAETs were found in these 
studies. The absorption spectra of the open-ring isomers were shown to depend on the nature 
of the cycloalkene moiety. The closed-ring isomer of the maleic anhydride derivative 10b had 
the absorption bands shifted to the longer wavelengths when compared with the 
perfluorocyclopentene derivative 3b. Expansion of the π-conjugated chain by introduction of 
phenyl groups at the 5- and 5'-positions of the thiop ene rings (compound 7b) resulted in a 
bathochromic shift. Compound 7b had the long-wave maximum shifted to 562 nm, 
comparing to 534 for 10b.  
The absorption maximum can be shifted even further (to 597 nm) by incorporation 
electron-donating diethyl amino groups at the 4- and 4'-positions of the phenyl substituents, 
compound 12b42. Useful insights were documented in studies of asymmetrical DAETs 
possessing an indole at one side and a thiophene at the other side of the molecules. The 




Figure 1.4. Absorption maxima of the selected closed-ring isomers of DAETs34,36,42,45,46,47 
 
Introductions of an electron-donating group into indole ring (13b) or an electron-
withdrawing group into the thiophene ring (14b) were both shown to shift the absorption 
maxima to longer wavelengths. Simultaneous presence of both electron-donating and 
electron-withdrawing substituents was shown to cause even larger shifts: to 680 nm in 15b 
and to 665 nm for the perfluorocyclopentene analogue 16b. Moreover, introduction of a 
strong electron-donating benzodithiole substituent a d a strong electron-withdrawing 
dicyanoethylene substituent at the 5- and 5'-positions of the thiophene rings coursed 
significant shift of the absorption maximum of the closed-ring isomer 17b to 828 nm45. 
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Another practically important absorption characteristic is the molar absorption 
coefficient. High sensitivity requires high molar absorption coefficients and high quantum 
yields. In general, introduction of electron-rich sub tituents or large-π conjugated systems in 
DAETs was shown to effectively increase both the parameters48,49.  
It has been shown that DAETs with five-membered heterocyclic rings populate two 
conformations in solution: parallel (CS symmetry) and antiparallel (C2 symmetry)
34,35,42. The 
ratio of the two conformations is normally around 1:1. As shown in the Fig.1.5, the 
photocyclization reaction can proceed only with theDAET molecules in the antiparallel 
conformation. Therefore, the cyclization quantum yields cannot exceed the molar fraction of 
the antiparallel conformation. 
 
Figure 1.5. Parallel and anti-parallel conformations of DAETs in the photoisomerization 
process. 
 
Literature quantum yields of several DAETs with ~1:1 ratios are summarized in the 
Table 1.3. The parallel/antiparallel ratio of the conformers could be shifted by steric 
constrains in the molecules causing one of the conformations to be energetically more 
favorable. To enhance the quantum yield it is therefore necessary to increase the abundance 
of the antiparallel conformation. One way to do this was suggested to be through introduction 
of bulky substituents to the thiophene rings. Such effect was illustrated on DAETs with 
benzothiophene rings substituted by isopropyl groups at the 2- and 2'–positions50. In line with 
this observation, for compounds 7a and 12a almost all photoexcited molecules were present 






Table 1.3. Quantum yields of cyclisation and cycloreversion reactions for selected DAETs. 
Compound Quantum yields Reference 
 cyclization cycloreversion  
10 0.21 0.13 46 
6 0.68 0.013 36 
7 0.46 0.015 36 
12 0.37 0.0025 42 
8* 0.9 0.025 37 
*ratio of conformers is shifted to anti-parallel.  
 
Another approach to increase the antiparallel conformation population was shown for 
DAET molecules confined in a hollow host. Since theDAET molecules in the antiparallel 
conformation have extended rod-like structures and should be more compact in the parallel 
conformation, the shape difference can be used to stabilize one of the conformations. 
Cyclodextrins were suggested as the host molecules for this purpose51,52,53. 
 
 
Figure 1.6. Schematic illustration of the DAET 18a in anti-parallel conformation included 
into cyclodextrin cavity. 
 
If the cyclodextrin cavity fits more to the rodlike structure than the compact structure, 
the latter is rejected from the cavity (Figure 1.6.). Indeed, compound 18a demonstrated 
increased ratio of the antiparallel conformation and higher quantum yield of the 
cycloconversion in the presence of β- or γ-cyclodextrins. Such “external” modulation of 
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photochromic properties of DAETs was called “gated photochromism”54. Gated 
photochromism have been extensively studied for different applications including 
photosensors and probes for controlling various chemical and physical properties with 
light37,55,56. 
 
1.3.3. DAET-based fluorescent probes  
 
Since the photoisomerization of DAETs can modulate their fluorescence 
characteristics, several attempts were done to employ DAETs for fluorescent bioimaging57,58. 
Notably, DAETs have been known to exhibit the fluorescence only in the open-ring forms. 
Generally DAETs do not show strong intrinsic fluoresc nce. To improve the 
fluorescence quantum yield the DAETs could be modifie  by introduction of an additional 
fluorophore. Some examples of employing additional chromophores, such as anthracene, 4-
amino-N-methylphthalimide, 2,4,5-triphenylimidazole, p-phenylethene are shown in the 
Figure 1.7.59,60,61,62,63. 
Another approach to optimize the DAETs fluorescent properties consists in oxidation 
of the sulfur atoms in the heteroaromatic rings64,65. The changes of the sulphur oxidation level 
strongly influenced the fluorescent and photochromic properties in benzothiophene 
containing DAETs, as shown in Figure 1.8. The fluorescence of closed-ring form 23b became 
stronger comparing to the open-ring form 23a. Such a high fluorescence quantum yield of the 
closed-isomer like found for 23b is unique to the oxidized DAETs.  
These and similar fluorescent DAETs could be useful as labels for probing the DAET 
microenvironment, e.g. within intracellular objects, organelles, or in particular, be used as 
membrane fluorescent probes. For example compound 20a showed a positive solvatochromic 
effect of the emission maxima, and its fluorescence quantum yield decreased in proportion to 






Figure 1.7. Different fluorophores conjugated with the diaryleth ne moiety in order to 




Figure 1.8. (a) Oxidation reaction by m-chloroperbenzoic acid of 5a into 23a; (b) 
photoisomerization of DAET 23; (c) and (d) are the fluorescence spectra of 5 and 23, 









1.3.4. Applications of DAETs in biological systems 
 
Besides a broad application in photonic devices DAETs have found important use in 
biochemistry, biotechnology and cell biology, in particular, for development of biosensors, 
analysis of biological dynamics, and in live cell imaging. 
Namely, fluorescent DAET-derivatives have been used to develop probes for detection 
of metal ions.  These probes are useful for investigation of environmental and biochemical 
processes in which metal ions such as Zn2+ are essential. The probe molecules combine the 
ion-sensing and DAET units. In one example, a photochromic thiophene-containing DAET 
was linked with terpyridine units via a phenylene linker (compound 26a)66. In another work, 
a DAET-derived Schiff base ligand was synthesized (compound 24a)67. Metal ion 
coordination to such compounds gave rise to a reversibl  changes in the emission band 
intensity and wavelength maximum.  
A DAET-based compound was reported in an application f r photocontrollable 
fluorescent labeling of biomolecules68. The compound featured a photochromic DAET 
moiety, a fluorescein-derived fluorophore, and an amine-reactive succinimidyl ester fragment 
(Figure 1.9., compound 27a.). This DAET derivative displayed modulation of the 
intramolecular energy transfer from the fluorophore to the DAET moiety by light. The 
fluorescence of 27a quenched upon photocyclization because of the spectral overlap of the 
absorption band of the closed-ring form (acceptor) with the emission band of the fluorophore 
unit (donor). Owing to the DAET moiety photoisomerization the fluorescence intensity of the 
compound decreased significantly upon irradiation with UV light but could be fully 
recovered after irradiation with visible light.  
An amphiphilic DAET derivative composed of hydrophilic and hydrophobic chains 
attached to the aryl groups of DAET core has been developed as a photoswitchable probe for 
living cells imaging (Figure 1.9., compound 25a)69. It was used as a cell-permeable cellular 
biomarker with low cytotoxicity. The molecule formed stable (vesicle-like) nanostructures in 
aqueous solutions. Isomerization to the closed-ring form is accompanied by fluorescence self-
quenching due to extension of the π-electron delocalization. This chromophore showed 
reversibility of the fluorescence switching inside the cell. It demonstrated descent 
biocompatibility and low toxicity that was confirmed with an MTT assay and trypan blue 






Figure 1.9. Selected fluorescent probes developed for biological applications constructed 
through conjugation of the DAET unit with an established fluorophore (from 66,67,68,69). 
 
In another study, reversibly photoswitchable dendritic nanoclusters for fluorescence 
imaging in vivo were developed70. Dendrimers oligomerized with a DEAT derivative cross-
linker to form a nanocluster, which was labeled with a standard fluorophore. The DAET unit 
was able to reversibly quench the fluorescence of the fluorophore inside the nanocluster 
through fluorescence resonance energy transfer (FRET). This effect was demonstrated using 
HeLa cell cultures and in in vivo experiments with zebrafish where these dendrimeric 
nanoclusters repeatedly switched “on” and “off” with contrast inside the cells without any 
apparent toxicity.  
 
1.4. Membrane-active peptides  
 
Membrane-active peptides are a class of peptides whose macroscopic biological 
activity is propagated through interaction with cell membranes. The major group of them is 
various membrane-damaging cytotoxic peptides. Perhaps the most well-established are the 
so-called antimicrobial peptides (AMPs) that are int gral parts of innate immune systems of 
virtually all multicellular organisms and functionally serve as the first-line host defense tools 
against opportunistic microorganisms71,72. The antimicrobial membrane-active peptides are 
frequently believed to share such common features as a small size (6-59 residues), high 
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positive net charge (abundant in Arg and Lys residues) and the ability to adopt simple 
amphipathic secondary structures (e.g. α-helical or β-sheet) in the presence of lipid 
membranes73,74. Notably, some of the AMPs have pre-defined structures already in aqueous 
environments, i.e. even before binding to the membrane, for instance due to the cyclic overall 
structure or constrains imposed by disulfide bridges. 
The mechanisms of action of AMPs were established to manifest through the 
unspecific binding to the lipid bilayers of cell mebranes, followed by enhanced membrane 
permeabilization and collapse of the transmembrane electrochemical gradients. Different 
mechanistic models of particular AMP/membrane interactions have been proposed. The 
“barrel-stave” and “wormhole” models assume that AMPs, especially α-helix structured, 
collectively form transmembrane permanent or transient pores in membrane bilayers75. These 
models are favored for the α-helically structured peptides and require peptides’ insertion into 
the membrane. Alternative, “carpet” or “detergent-like” mechanism of action was proposed 
for the AMPs that are not inserted deeply into the lipid bilayer, but rather bind peripherally to 
its surface and cause mechanic membrane disintegration at the threshold concentrations76. 
Despite abovementioned common features and modes of peptide-bilayer interactions, 
the spectra of species-specific activities for particular AMPs are known to vary 
significantly76,77,78. The attempts to rationalize these across-kingdom selectivity observations 
centered around general differences in the lipid comp sition of the pro- and eukaryotic cell 
membranes. Explanations took into account protagonisation of the degree of lipid saturation, 
the presence of sterols, bilayer thickness and curvat e, but most often the net charge of the 
plasmalemma and the across-membrane potential. The sel ctivity against bacteria in 
particular was explained by the higher affinity of the highly cationic AMPs to the negatively 
charged bacterial cell membranes. Noted by similar connotations with respect to the overall 
negative cell-surface charge of the transformed cancer cells, some AMPs have been studied 
as non-specific membranolytic anticancer agents, showed indeed cytotoxic effects on the 
cancer cells and were therefore postulated as promising therapeutic agents for the cancer 
treatment79. 
 
1.4.1. Peptides employed in this study 
 
Several structurally different membrane active peptides, namely: a cyclic Gramicidin 
S, a β-stranded fragment of the polycationic β-sheet [KIGAKI]3, a short α-helical BP100, and 
a β-hairpin-folded SVS-1 have been used in this study.  
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Gramicidin S (GS) is a cyclic decapeptide antibiotic with a sequence of cyclo(Val-
Orn-Leu-DPhe-Pro)2 that was isolated from the soil bacterium Aneurinibacillus migulanus 
(formerly Brevibacillus brevis) in 1942 80. It has antiparallel β-sheet conformation stabilized 
with two type II' β-turns formed around the DPhe-Pro fragments. The GS molecule is 
amphipathic: two polar positively charged ornithine side-chains are directed to one side of the 
β-sheet while four hydrophobic side-chains are pointing o the opposite direction81. GS shows 
activity against broad spectrum of Gram-positive and Gram-negative bacteria, pathogenic 
fungi82. However, due to the high hemolytic activity it is u ed only for topical applications.  
The cationic peptide [KIGAKI]3 is a model peptide that was designed as an ideal 
amphipathic β-strand with antimicrobial activity83. This peptide was used for the study of the 
β-aggregation in membranes, where it was shown to adopt a highly amphipathic β-sheet 
structure when bound to the lipid bilayer at elevatd concentrations. Comparing to the α-
helical peptides from which it was originated, the [KIGAKI] 3 has shown higher antimicrobial 
activities and was less hemolytic, therefore it is potentiated as a promising antimicrobial 
agent. 
BP100 (KKLFKKILKYL-NH 2) is a short cecropin A-melittin hybrid peptide obtained 
through a combinatorial chemistry approach84. It is active against Gram-negative bacteria and 
was shown to be effective in i  vivo tests for growth inhibition of the plant pathogenic 
bacteria. In the case of eukaryotic cells it was shown to act as a cell-penetrating peptide85 and 
recently also its fusogenic activity in the model membranes was shown98. 
SVS-1 [KVKVKVKV DPPTKVKVKVK-NH2] is an 18-residue peptide that was 
designed to adopt an amphipathic β-hairpin when bound to negatively charged cell 
membranes86. It is constructed of two strands of alternated valine and lysine residues being 
connected by a type II' β-turn fragment (-VDPPT-). The peptide was shown to possess toxicity 
against cancer cells and at the same time reduced hemolytic potential. This selectivity of the 
peptide was attributed to the ability of a β-sheet to self-assemble in the presence of negatively 
charged cancer cell membrane. The all-D isomer of the peptide was shown to have the same 
cytolytic properties, thus SVS-1 was concluded to act through direct membrane lysis and not 
to involve any receptor-mediated process. Also as acontrol peptide an analogue (SVS-2) was 
studied. SVS-2 contains only single residue substitution: here L-proline is used instead of 
original D-proline. Such minimal modification destroys β-turn and disables therefore 
formation of the β-hairpin. Consequently, SVS-2 appeared not to have cytolytic activity 




1.5. Photocontrol of the peptide conformation and function 
 
Three principally different methods that were used to incorporate photoresponsive 
switches in peptides were described in the literature (Figure 1.10.).  
It should be noted that in all studies except a few r ports the molecular switches other 
than DAETs were used until now87,88. Most often, the azobenzene fragments were 
incorporated into peptides as the photoswitching units. This imposed some restrictions on 
application of the photoswitchable peptides due to limitations known for the azobenzenes. 
The main problems were thermoreversibility of azobenzenes, their low chemical stability and 
non-complete conversion efficiency between the two forms. Therefore, the use of DAET-




Figure 1.10. Main approaches used to modify peptides with molecular switches. (a) 
Incorporation of the amino acid derivatives with photoresponsive side-chains into peptides. 
(b) Introduction of molecular switches directly into the backbone of cyclic or linear peptides. 
(c) Cross-linking the amino acid side chains in peptides with molecular switches. Adapted 








1.5.1. Peptides with photoresponsive amino acid residues 
 
Photoresponsive peptides were investigated for the first time by Goodman already in 
1960th, structural changes of photoswitch-modified peptide erivatives induced by light 
exposure was demonstrated89. Copolymers of phenylazophenylalanine and γ-benzyl-glutamic 
acid were prepared. Changes in Cotton effect were observed upon irradiation, indicating 
light-induced structural changes of the polypeptide backbone as was confirmed by circular 
dichroism. Further extensive studies of such system showed that photoisomerization of 
photochromic residues can induce major conformationl changes in peptide structure 
90,91,92,93. However, to achieve significant influence the number of the incorporated 
photoswitchable amino acids had to be high; up to 40% of all amino acid residues should be 
present in the modified peptide.  This drawback is a limiting factor for broad applications of 
such systems. Later on, other methods for peptide modification with molecular photoswitches 
were developed and they showed much more promising results. 
 
1.5.2. Peptides with the photoresponsive backbone  
 
Perhaps the most prominent example of the peptides bearing the photoresponsive 
backbone is the illustrated in Fig. 1.11. photosensitive azobenzene-modified cyclic hepta- and 
hexapeptides which allowed photocontrol of cell adhesion94. The designed peptidomimetics 
have the Arg-Gly-Asp (RGD) sequence as active functio ing moiety. This is the ubiquitous 
motif which is recognized by integrin cell-surface receptors of a large number of adhesive 
extracellular matrices, blood cells, and cell-surface proteins. Photocontrol of the RGD-
containing peptides was proposed as a tool for investigating or modifying the intermolecular 
adhesion95. In this particular example, the photosensitive peptid s contained photoswitching 
4-[(4-aminomethyl)phenylazo]benzoic acid (AMPB) residue as a part of the peptide 
backbone, along with the RGD motif. It was found that the conformationally more 
constrained trans-azobenzene-modified cyclic peptide 28 showed a higher binding affinity 
for αvβ3 integrin than the cis form. Shift of the lysine position (peptide 29) caused significant 
reduction in the affinity to the immobilized integrin. However, the difference in affinities 
between the cis- and trans-peptides increased by more than a factor of 2 and therefore 





Figure 1.11. Affinities of the azobenzene-modified cyclic peptides 28 and 29 to surface-
immobilized αvβ3 integrin96. “cis” relates to the photostationary state with 80% cis-azo 
isomer, and “trans” relates to the thermally relaxed molecule with 100% trans-azo isomer. 
Adapted from ref. 12. 
 
Many other photoresponsible cyclic peptides have ben reported in last two 
decades97,99. For example, the photosensitive peptide hormone smatostatin that regulates a 
range of biological functions, including cell growth100 and cyclic, AMPB-modified peptide 
derived from the binding site of the PDZ domain of neuronal nitric oxide synthase that is 
participate in muscle contraction101. 
The modification of β-hairpin structured peptides with photoswitchable units shares 
the structural principle with cyclic peptides and is based on the replacing the β-turn region 
with the molecular switch. The stability of the secondary structure of the β-hairpin peptides is 
somehow weaker than that of the cyclic peptides and depends stronger on the interaction 
between the linked antiparallel peptide strands (i.e., hydrogen bonding and side chain–side 
chain interactions)102. 
The photoswitchable β-hairpin peptide 30 (a modification of the 12-residue peptide 
sequence derived from the protein GB1) that has a DPro-Gly motif in the β-turn replaced with 
an azobenzene switch was studied (Fig. 1.12.)103,104. NMR spectroscopy revealed that cis-30 
adopted a well-defined β-hairpin structure resembling the parent peptide. However, the trans 
configuration was shown to be less structured; higher order of aggregation was documented 
for this configuration. The trans-30 reversibly switched on/off several times until the 





Figure 1.12. Model hairpin peptidomimetic 30 containing a cis-azobenzene (3-(3-
aminomethylphenylazo)phenylacetic acid, AMPP) as a turn element, shown with the 
hydrogen bonding pattern of the β-hairpin  (from ref. 12,103). 
 
Other examples of photoresponsive β-hairpin peptides have been reported105. The β-
hairpin folding and unfolding process was photocontr lled in tryptophan-rich model peptides, 
the secondary structure of which is stabilized by the effect called “tryptophan zipper”106,107. 
In other works successful incorporation of the stilbene chromophore in the peptide backbone 
was demonstrated108,109. 
 
1.5.3. Peptides with photoresponsive cross-linked side chains 
 
α-helix is one of the most abundant secondary structu e elements in natural peptides 
and proteins. Thus, photocontrol of the α-helical peptide structure could help in developing 
powerful instruments for medicinal applications of peptides as well as for understanding the 
mechanisms of their biological action in biological systems.  
The control over the α-helix folding could be achieved by introducing two cysteine 
residues into peptides and cross-linking these with a photoresponsive bridging unit of the 
length, matching in one of the photoforms the distance expected for an α-helix110,111. For 
example, the cysteine residues were introduced at i and i+7 positions in a model peptide JRK 
(Figure 1.13.)112. The positions were selected to match the linker length in the azobenzene cis
configuration. As indicated by CD measurements, the isomerization of the azobenzene switch 
from trans to cis configuration increased the helical content from 12% to 48%.  
The role of the linker length, its flexibility, position of the cross-linked amino acids 
and type of molecular switch were addressed in the above cited and similar studies 12,113. 
These studies not only successfully demonstrated th possibility to control the α-helical 
folding by photostimulation, but also suggested general principles useful for developing 





Figure 1.13. Direct photocontrol over the α-helix folding. (a) Chemical structure of the 
azobenzene containing cross-linker “Azo”, (b) models showing the decreased helicity 
induced in the FK-11-X peptide upon trans-to-cis isomerization of the attached azobenzene 
cross-linker. (c) Models showing the increased helicity in the JRK-X peptide induced upon 
trans-to-cis isomerization of the attached azobenzene cross-linker. The peptide sequences are 





2. Aims of the present study 
 
The incorporation of molecular photoswitches into peptides or proteins should allow 
reversible control of their structure and functions by means of photoisomerization. The aim of 
this study was to explore the practical possibilities of polypeptide modification using 
photoswitchable diarylethene-based building blocks, and to investigate the effects of the 
photoinduced isomerization on the structure and functio  of several biologically active 
peptides. 
  
Specific goals of this work were: 
- Design and synthesis of molecular photoswitches based on diarylethene derivatives as 
building blocks to make them suitable for direct incorporation into peptides via routine 
peptide synthesis protocols. 
- Synthesis of diarylethene modified photoresponsive peptidomimetics based on two 
biologically active molecules (antimicrobial gramicidin S, anticancer peptide SVS). 
- Fundamental characterization of the peptidomimetics in terms of their physico-chemical 
properties, and establishment of protocols for their photoisomerization. 
- Characterization of the core diarylethene chromophore with respect to its influence on 
the secondary structure of peptide models (α-helices, β-strands). 
- Characterization of the photoresponsive peptides in cellular assays in terms of their 
biological functions (antimicrobial, hemolytic, cancer proliferation). 
 
Peptidomimetics that were designed and studied in th s work can find practical 
applications: in the development of novel medical approaches, in particular for 





3. Results and Discussion 
 
3.1. Development of novel DAET building blocks for incorporation into peptides 
 
The diarylethene unit requires specific modifications in order to be incorporated into 
peptides. In particular, carboxylic and N-Fmoc protected amino groups have to be introduced 
into the molecule. Besides, to be applicable in the Fmoc strategy of solid-phase peptide 
synthesis (SPPS) the building block has to be resistant to aggressive reagents including 
piperidine and trifluoroacetic acid. 
 
3.1.1. The building block containing hydrazide group as an amino group surrogate (SwI) 
 
To satisfy the above described requirements a building block 31 (Fmoc-SwI) - an 
amino acid mimic - was designed. It has a carboxylic group directly attached to one of the 
thiophene ring and a hydrazide group attached to the second ring (Scheme 3.1.). It should be 
noticed that direct attachment of the amino group to the thiophene ring is avoided in the 
design. This is important, because the aminothiophene-derived diarylethene systems are 
known to be sensitive to oxidation114. In the following, for the notion of the building block 31 
and the residue of 31, respectively Fmoc-SwI and SwI, will be used. The peptides employing 
SwI are discussed in more details in the Chapters 3.2., .3., 3.5., while Chapters 3.4., 3.6. are 
describing the SwII-based peptides. 
 
Scheme 3.1. Synthesis of the photoswitchable building block 31 (Fmoc-SwI) containing a 




In order to synthesize Fmoc-SwI, the diarylethene derivative 8a functionalized with 
two carboxylic groups was selected as the direct precursor (Scheme 3.1.). Synthesis of this 
diacid was described in the literature and can be up-scaled to tens of grams27. In order to 
introduce the Fmoc protected amino group surrogate, compound 8a reacted with one 
equivalent of Fmoc-hydrazide in the presence of coupling reagents (DIC/DIPEA). Since 8a 
has two carboxylic groups which can compete in the reaction with Fmoc-hydrazide, the final 
product contained 25% of the non-reacted diacid 8a, 50% of the mono-substituted target 
product Fmoc-SwI and 25% of the double-modified by-product 32. The crude material was 
washed with 0.5 M solution of aqueous sodium bicarbonate in order to get rid of the non-
reacted diacid 8a. The sodium salt of Fmoc-SwI remained in organic solvent due to its high 
hydrophobicity, while the sodium salt of 8a transferred to the aqueous solution and discarded. 
The by-product 32 did not interfere with the following peptide synthesis, therefore, 31 was 
used as obtained containing the by-product. Pure Fmoc-SwI and 32 were obtained for the 
identification using preparative RP-HPLC.  
As was tested (see discussion below) the building block is fully compatible with 
SPPS. It can be used as a normal Fmoc-protected amino acid in the automated peptide 
synthesis allowing to prepare peptides in a routine way. The backbone of a peptide with 
introduced building block Fmoc-SwI is shown in Figure 3.1. Major conformational changes 
of the peptide backbone are expected to be occurring during photoisomerization of the DAET 
unit.   
 
 
Figure 3.1. Peptide backbone modified using photoswitchable building block Fmoc-SwI.  
 
In order to evaluate the SwI photochromic and fluorescent properties, a small wter-
soluble peptidomimetic (KI-SwI, sequence: KIGAKI-SwI-KIGAKI) was constructed (see 
protocol in Chapter 6.2). The peptidomimetic was deigned to have no natural amino acids 
that can interfere with the absorption and fluorescence of the photoswitchable unit. RP-
HPLC-elution profiles of the purified peptide were recorded before and after the irradiation 
with UV light (Figure 3.2.). As can be seen, complete conversion from open-ring form (black 
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line) to colored closed-ring form (red line) can be achieved after irradiation with UV light. 
Furthermore, the obtained colored closed-ring form converted back to the open-ring form 
after irradiation with visible light. The peptidomietic in closed-ring form was found to 
possess shorter retention time contrary to the open-ring form. The effect is most probably due 
to changes in the hydrophobicity of the photoswitchable unit SwI (open-ring vs. closed-ring), 
because the glycine-containing small peptidic part is unlikely to be folded under the RP-
HPLC conditions.  
 
 
Figure 3.2. Analytical RP-HPLC of the peptide KI-SwI before irradiation with UV light 
(black line) and after it (red line) (chromatographic conditions see in Chapter 6.). 
 
The absorption and fluorescent spectra of the KI-SwI were recorded in water solution 
for both photoforms (Figure 3.3a). The open-ring form absorbed in the UV region, and the 
closed-ring form revealed two bands in the visible region, at 349 and 536 nm.  
The fluorescent properties of the SwI unit were also studied. In Figure 3.3b a spectrum 
of the KI-SwI fluorescence (excitation at 295 nm) in the open-ring form is shown. The 
peptide gave green fluorescence with a maximum at 430 nm. Interestingly, the highest 
fluorescence quantum yield was observed with the excitation at 295 nm, while the 
corresponding absorption maximum was at 265 nm. Perhaps, during the excitation of the 
open-ring form two competing processes occurred: conversion to the closed-ring form and 
the fluorescence emission. As was expected for this type of DAETs, the closed-ring form 





Figure 3.3. (a) Absorption spectra of the open-ring and closed-ring forms of the 
peptidomimetic KI-SwI recorded at 30 µM concentration in 10 mM phosphate buffer (pH 7.4) 
at ambient temperature. (b) Fluorescence spectrum of the peptidomimetic KI-SwI in open-
ring form; 21 µM in 10 mM phosphate buffer (pH 7.4); excitation at 295 nm, ambient 
temperature. 
 
3.1.2. Building blocks containing proline as an amino function (SwII ) 
 
Due to expected chemical instability of the hydrazide fragment, the building block 
Fmoc-SwI was redesigned to avoid this drawback. Different type of building blocks (SwII) 
was developed, where a residue of an amino acid was used instead of the hydrazide group.   
On the contrary to the rotationally flexible hydrazide group the backbone of an α-
amino acid has more defined conformation. Therefore in this type of building blocks it should 
be possible to fine adjust geometrical position of the amino function with respect to the 
DAET core by simply varying the amino acid residue. In this work two DAET building 
blocks of the SwII type were synthesized: one with the residue of L-proline (Fmoc-SwLPro) 
and another with the residue of D-proline (Fmoc-SwDPro).  
The synthesis of new building blocks was performed starting from compound 33 
(Scheme 3.2.). Compound 33 was synthesized according to the published protocol27. It has 
chloride substitutions at the 2- and 2'-positions of dithienylcyclopentene molecule that can be 
lithiated in order to functionalize the thiophene rings. Importantly, selective monolithiation 
was also possible for 33. Treatment of 33 with one equivalent of n-butyllithium in an inert 
atmosphere at -78 °C led to the monolithiation. Followed addition of the dimethylformamide 
gave the mono-formylated derivative 34 with almost quantitative yield of 90%. The formyl 






Scheme 3.2. Synthetic route for the preparation of the photoswitchable building block Fmoc-
SwLPro. 
 
The second functional chloride group in 35 was then lithiated and reacted with N-Boc 
protected L-proline-derived Weinreb amide (36). Compound 36 was synthesized according to 
the published protocol115. The formyl group in the resulting product 37 was oxidized with 
silver oxide to yield the carboxylic group (compound 38). The final building block 39 (Fmoc-
SwLPro) was obtained after exchanging the Fmoc-protection for the Boc-protection at the 
proline residue. The same synthetic approach was also used for the preparation of D-proline 
containing building block (Fmoc-SwDPro). 
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As described above, the method was illustrated on the example of a proline residue 
incorporation into the photoswitchable building blocks. However, other protected amino acid 
Weinreb amides can be used in order to obtain other DAET building blocks suitable for 
SPPS. 
 
3.2. Photoresponsive linear model peptides with the SwI building block 
 
First, the photoswitchable DAET building block Fmoc-SwI was incorporated in linear 
peptidomimetics. This allowed (i) verification of the building block compatibility with the 
standard SPPS procedures; (ii) assessment of the exent of the conformational perturbation 
imposed by the DAET switch onto different secondary structure elements as well as (iii) 
evaluation of efficiency of the photoswitching process in membrane environments.   
Two model peptidomimetics were designed: an asymmetric “β/α-model peptide” and 
a symmetric “α/α-model peptide”. The first comprised a β-strand connected successively to 
the SwI unit and a short amphipathic α-helix; the second has two identical α-helices 
connected by their N-termini to the DAET fragment (Figure 3.4.). The choice of the 
polypeptide units was made considering their small size and amphipathic nature, to interact 




Figure 3.4. Modular build-up and expected orientations of the lin ar model peptidomimetic 
with the DAET unit in the middle of the polypeptide backbone: (a) “β/α-model peptide”; (b) 
“ α /α-model peptide”. The non-perturbed “ideal” conformational states are illustrated as a 
flat arrow (β-part) and as solid cylinders (α-part). N- and C-termini of the peptidic units are 
indicated. Photoswitchable DAET unit is colored in blue. Lipid bilayers are drawn not to the 
scale and illustrate only overall expected peptide opologies. 
 
Thus, the β-stranded unit of the final constructs was an octapeptide derivative of the 
antimicrobial peptide [KIGAKI]3, while the α-helix unit was derived from the complete 
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sequence of the membrane-active peptide BP100.  Both parent peptides were extensively 
studied previously by solid-state 19F-NMR116,117, and were known to possess very stable 
amphipathic secondary structures over broad range of membrane compositions and 
concentrations. 19F-NMR data (19F dipolar couplings at different locations along the 
sequence) were known for both units. 
 
3.2.1. Peptide synthesis 
 
 The designed peptidomimetics were prepared with peptid  units constructed using 
canonical amino acids (the “wild type”) for the CD investigation in solution. In addition, a 
series of singly or doubly amino acid-substituted 19F-labelled analogues of all the 
peptidomimetics were obtained for the 19F-NMR measurements. The analogues contained an 
artificial amino acid CF3-Bpg (L-3-(trifluoromethyl)bicyclopent-[1.1.1]-1-yl glycine, 
19F-
label)118 in place of a non-polar residue. CF3-Bpg was designed as an ideal 
19F-label for 
substituting hydrophobic residues as it resembles co ely Val, Leu, Ile, Met in terms of 
hydrophobicity and size. Moreover, the CF3-Bpg side chain hydrophobicity allows the 
substitution of this 19F-label for Ala and aromatic amino acid residues, since such exchanges 
were demonstrated to influence neither structure nor function of antimicrobial peptides over 
many examples119. The CF3-Bpg was applied here in the same fashion as was routinely used 
in the solid-state 19F-NMR structural studies of membrane-active peptides b fore120,121.   
Overall, ten 19F-labeled analogues of the “β/α-model peptide” were synthesized, four 
with the 19F-labels in the β-strand region and six with the labels in the α-helical fragment. The 
amino acid sequences of the synthesized peptidomimetics are shown in the Table 3.1. For this 
group of peptides the synthesis was carried out with manual SPPS (Fmoc strategy) in 
conventional way where the Fmoc-protected DAET unit was introduced just like any other 
amino acid (details are described in the Chapter 6.2.1.)  
The α/α-model peptide was also prepared “wild type” for CD study and labeled for 
19F-NMR measurements. Five CF3-Bpg-containing analogues were produced, each 
possessing two fluorine labels, one in every copy of the α-helix (Table 3.2.). Since the model 
consisted of two identical α-helical fragments the N-termini of which were connected by the 
building block 8a (DAET diacid), the following procedure was used. Complete helical 
sequences were built first on the solid support using automated SPPS. The Fmoc-deprotected 
polypeptide chains were cross-linked in one step with the DAET building block 8a while 
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remaining bound to the resin. The detailed synthetic procedure is described in the Chapter 
6.2.2. 
 
Table 3.1. List of the synthesized 19F-labelled analogues of the β/α-model peptide.  
Peptide  Sequence* 







β8I/α  KIKIGAK- CF3-Bpg-Sw
I-KKLFKKILKYL-NH 2 
β/α3L KIKIGAKI-Sw I-KK-CF3-Bpg-FKKILKYL-NH 2 
β/α4F KIKIGAKI-Sw I-KKL- CF3-Bpg-KKILKYL-NH 2 
β/α7I KIKIGAKI-Sw I-KKLFKK- CF3-Bpg-LKYL-NH 2 
β/α8L KIKIGAKI-Sw I-KKLFKKI- CF3-Bpg-KYL-NH 2 
β/α10Y KIKIGAKI-Sw I-KKLFKKILK- CF3-Bpg-L-NH2 
β/α11L KIKIGAKI-Sw I-KKLFKKILKY- CF3-Bpg-NH2 
* SwI denotes the residue of the building block 31.  
 
 
Table 3.2. List of the synthesized 19F-labelled analogues of the α/α-model peptide.  
Peptide Sequence* 
α/α-model peptide (wild type) SwA(KKLFKKILKYL-NH2) 2 
α/α-3L SwA(KK-CF3-Bpg-FKKILKYL-NH2) 2 
α/α-4F SwA(KKL- CF3-Bpg-KKILKYL-NH2) 2 
α/α-7I SwA(KKLFKK- CF3-Bpg-LKYL-NH2) 2 
α/α-8L SwA(KKLFKKI- CF3-Bpg-KYL-NH2)2 
α/α-10Y SwA(KKLFKKILK- CF3-Bpg-L-NH2)2 
* SwA denotes the residue of the diacid 8a.  
 
Gratifyingly, no side-reactions were observed during the synthesis of the β/α-models. 
The crude peptidomimetics were standardly purified on the preparative RP-HPLC column 
and 100% purity was confirmed by analytical HPLC after lyophilization. On the contrary, 
crude materials of the cross-linking syntheses (α/α-model peptide) revealed completely non-
coupled peptide chains alongside with the target products, as well as mono-reacted CO2H-
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SwA-peptide derivatives. The target peptidomimetics were identified with the MALDI 
analysis and separated as described in Chapter 6.2.2.
The elution profiles of the purified peptides of both “wild type” models were recorded 
before and after the irradiation with UV light (Figure 3.4.). It was possible to quantitatively 
convert the open-ring forms into the closed-ring forms by the irradiation with UV light. The 
reverse reactions (decoloration) under the exposure to the visible light were found to proceed 
completely as well. In both model peptides moderate changes in the retention times (<5 min) 
were observed during the photoisomerization. The shift was in the same direction and value 
as was observed earlier in a similar study on another linear peptide derivative (see Chapter 
3.1.1.). Presumably, the RP-HPLC retention time difference reflected intrinsic differences in 
the hydrophobicities of the two DAETs photoforms, with the constrained closed-ring 
compounds being slightly more polar. 
 
 
Figure 3.4. Analytical RP-HPLC of the α/α-model peptide and β/α-model peptide before 
irradiation with UV light (open-ring form, black line) and after it (closed-ring form, red line). 
(Conditions see in Chapter 6.). 
 
3.2.2. Conformational changes upon photoswitching in solution 
 
 CD spectra (Figure 3.5.) of both model peptides were r corded in order to observe 
changes in their secondary structure and evaluate po ntial conformational and spectral 
impact of SwI in different isotropic environments. No significant changes were observed 
during the photoisomerization for both models – the CD spectra were identical in the closed-
ring and the open-ring forms. One might conclude that conformational perturbation (at least 
in the selected models under tested conditions) caused by the photoswitching process seemed 
to be small if not completely absent. These measurements also demonstrated that the CD 
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spectral range useful for peptide structural analysis was free of any contribution from the SwI 
chromophore.  
 
Figure 3.5. CD spectra from linear model peptides in different environments at a 
concentration of 100 µg/ml.  β/α-model peptide (solid line) and α/α-model peptide (dashed 
line) in solution (a, d, 10 mM PB, pH 7.4); in deterg nt micelles (b, e, 25 mM SDS); in 
DMPC vesicles (c, f, P/L = 1/50). The peptides were in the open-ring forms (a, b, c) and in 
the closed-ring forms (d, e, f). 
 
 In addition, the CD data allowed obtaining useful insights into conformational 
properties of the peptidic units of the model peptides. According to previous studies, the 
parent peptides [KIGAKI]3 and BP100 should be unstructured in aqueous buffers. In the 
presence of lipid membranes, both peptides were known t  bind the bilayers and undergo 
structural transition to the amphipathic β-strand and α-helix, respectively116,117. In full 
accordance to this, the β/α-model peptides were unstructured in buffer solution, as their CD 
curves resembled that for a random coil (no positive bands and a pronounced negative band 
at ca 200 nm). The α/α-model peptide gave no signal in aqueous buffer at all, independently 
of the photoswitching process, that may be due to aggregation of the peptide, never observed 
for the stand-alone BP100 (the α-helical unit). As expected, both model peptides gave the CD 
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lineshapes with the dominating α-helical signal in SDS and DMPC vesicles, indicating the 
binding of peptides to the micelles/membranes. Notably, the α/α-model peptide gave the CD 
spectra characterized by stronger α-helical contribution, while for the β/α-model peptide the 
β-part in the membranes appeared to structurize independently. 
 
3.2.3. Conformational changes upon photoswitching in membranes 
 
Solid-state 19F-NMR measurements were performed for the model peptides labeled by 
CF3-Bpg in macroscopically oriented lipid bilayers. The studied peptidomimetics were 
reconstructed into a model lipid membrane (DMPC) at low peptide to lipid molar ratio 
(1:100) to avoid aggregation. The measurements weredon  below and above the main lipid 
phase transition temperature (at 15° and 40°C respectively; DMPC phase transition occurred 
at ca. 23°C) for each prepared oriented sample. In all the NMR experiments the oriented 
samples were aligned parallel to the magnetic field. The peptides were measured in both 
open-ring and closed-ring forms. Further details of the sample preparation and NMR 
spectroscopy are given in the Chapters 6.3. To check if oriented samples were prepared 31P-
NMR measurements were performed prior to 19F-NMR. Observation of the 31P-NMR signals 
from the phospholipids (headgroups of DMPC molecules), allows quantitative assessment of 
the degree of the peptidomimetic orientation in the lipid bilayers.  More than 70% lipids were 
found to be oriented in all the prepared samples, (data not shown), therefore, an assumption 
was made that the peptides should possess similar degree of alignment. 
 It was noticed above that the parent antimicrobial peptide [KIGAKI]3 was originally 
designed as an amphipathic β-strand. It was demonstrated to exist in a concentration-
dependent equilibrium between single-stranded monomeric form and the aggregated β-sheets 
in the membrane-bound state. Both forms can be distinguished by solid-state 19F-NMR. In the 
case of the single-stranded monomeric form a dipolar coupling of ca. +8 kHz should be 
observed, while the aggregated β-sheets are characterized by ca. +15 kHz splitting. Fi ure 
3.6. illustrates the solid-state 19F-NMR spectra for the β/α-model labeled in the β-stranded 





Figure 3.6. Representative solid-state 19F-NMR spectra of the β/α-model peptide CF3-Bpg-
labeled analogues. The peptides are measured with their SwI units being in the closed-ring 
state. The peptides were reconstituted in DMPC (P/L= 1:100) and measured at 40°C.  
 
As can be seen, all the measured peptides showed a single triplet with the positive 
coupling constants within 6.8-9-3 kHz range if their DAET fragments SwI were in the closed-
ring rigid state (see Table 3.3. for the coupling values). Such appearance is compatible with 
the highly dynamic β-strand bound to membrane such as the hydrophobic side-chains point 
towards the membrane interior, with the cationic side-chains of lysines pointing to the 
opposite direction, namely, to the aqueous phase. Slightly lower coupling constant values 
obtained for the peptidomimetics labeled at positions 4 and 8 could be explained by their 
proximity to the two strand-perturbing cites in the molecule (glycine and SwI residues, 
respectively), assuming that the SwI behaves as a β-strand breaker. In general, the spectra 
resembled closely the low-concentration (P/L<1:400) state of the parent 18-mer peptide.  
Interestingly, the characteristic coupling constant value of ca. +8.0 kHz for monomers was 
observed for the β/α-model peptide at a significantly higher P/L of 1:100 despite the 
similarity of the molecular size of the two peptides. Aggregation behavior of the β/α-peptide 
was not studied further but this discrepancy may be simply explained by the steric 
congestions imposed by SwI moiety which might prevent the β-sheet self-assembly122.    
 
Table 3.3. 19F-19F dipolar couplings of the β/α-model peptide analogues labeled in the β-
strand unit, as determined in the oriented DMPC bilayers at 40°C. 
State of the SwI Dipolar coupling (J, [kHz]) in: 
β2I/α β4I/α β6A/α β8I/α 
open-ring form 9.3 7.0 8.3 3.0 and 6.8 




When the SwI unit was converted to the open-ring flexible state, th  spectra of the 
peptidomimetics did not change, with a single exception observed for the peptidomimetic 
labeled at position 8, where the label is directly a tached to the photoswitch. As can be seen in 
the Figure 3.7., 6.8 kHz splitting persisted, but additional signal with ca. 3 kHz splitting 
emerged. Conversion back to the closed-ring form led to disappearance of this new signal, 
confirming that it was caused by the SwI photoswitching. The signal could be assigned to one 
of the two conformations of the open-ring SwI (i.e. parallel and antiparallel, see Chapter 
1.3.2.), that is in line with the above suggested β-breaking ability of the SwI unit.  
 
 
Figure 3.7. Solid-state 19F-NMR spectra of the β8I/α-peptide in DMPC (P/L = 1:100) at 
40°C. Upper line: the SwI in the open-ring form; bottom line: corresponding closed-ring 
form. 
 
Measurements at the temperature below the lipid phase transition did not reveal any 
difference comparing to the above described observations, except that the 19F-NMR signals 
were broadened as expected for peptides in less mobile gel-phase lipids.  
 Next, the α-helical part of the β/α- and α/α-model peptides was closely investigated by 
the analysis of 19F-NMR spectra of the peptidomimetics labeled in the α-helix units. The 
measurements were performed under the same conditions as describe above. The resulting 
spectra are shown in Figures 3.8 (β/α-model) and 3.9, 3.10 (α/α-model), the splitting values 
are summarized in Table 3.4. and 3.5. Like in the case of β/α model peptides, the spectra 
measured in liquid-phase bilayers featured relatively narrow signals while broad signals were 
observed at low temperatures, in some cases precise measurements of the dipolar coupling 





Figure 3.8. Series of solid-state 19F-NMR spectra of the β/α-model peptides labeled by CF3-
Bpg in the α-helical fragments in the oriented DMPC bilayers; (a), (c) at 40°C, (b), (d) at 
15°C; (a) and (b) correspond to the DAET unit being i  open-ring form, while (c) and (d) - in 




Figure 3.9. Series of solid-state 19F-NMR spectra of the α/α-model peptide analogues labeled 
by CF3-Bpg in the α-helical fragments in the oriented DMPC bilayers; (a), (c) at 40°C, (b), 
(d) at 15°C; (a) and (b) correspond to the DAET unit i  open-ring form, while (c) and (d) - in 





Scheme 3.10. Solid-state 19F-NMR spectra of α/α-model peptide in the oriented DMPC 
bilayers at 15°C (below lipid phase transition). Spectra of the closed-ring forms (red lines) 
aligned with corresponding spectra of the open-ring forms (black lines). 
 
Table 3.4. Fluorine dipolar coupling constants of the α-helical part of β/α-model peptide 
analogues as determined in oriented DMPC bilayers at 40°C and 15°C. 
State of the SwI Dipolar coupling (J, [kHz]) in: 
β/α-3L β/α-4F β/α-7I β/α-8L β/α-10Y β/α-11L 
open-ring form, 40°C 7.6 0 10.5 -5.4 3.8 8.3 
closed-ring form, 40°C 6.0 0 9.1 -5.4 3.6 7.4 
open-ring form, 15°C 9.9 -6 10 -6.6 0 7.7 
closed-ring form, 15°C -7.5 -5.6 9.2 -6.6 0 7.7 
reference*, 35°C 5.4 0 7.7 -4.6 2.6 6.1 
reference*, -20°C 4.5 -7.1 9.8 7.4 0 12.1 
*J values from the parent peptide as reported for the same labeling positions in the conditions of fluid or gel-
state bilayer of DLPC/DLPG123 
 
Table 3.5. CF3-group dipolar coupling constants of the α-helical part of α/α-model peptide 
analogues as determined in the oriented DMPC bilayers at 40°C and 15°C. 
State of the SwI Dipolar coupling (J, [kHz]) in: 
α/α-3L α/α-4F α/α-7I α/α-8L α/α-10Y 
open-ring form, 40°C 8.6 0 10.6 -5.3 4.5 
closed-ring form, 40°C 5.1 0 9.6 -4.7 3.4 
open-ring form, 15°C 5 -6.6 9.3 -6.8 0 
closed-ring form, 15°C 4.6 -6.6/12* 9.3/-6.4* -6.8/0* 0/12* 




 Remarkably, these spectra closely resembled the set of splitting pattern in the spectra 
of the parent BP100 peptide measured under similar conditions124. Even changes happened 
upon the liquid and gel-state bilayer phase transition (in particular, for the corresponding 
peptides labeled at positions Phe4 and Tyr10) are essentially similar, at least for the 
peptidomimetics with the SwI unit in the open-ring state.  
Comparison of the NMR data measured for the liquid-phase bilayer for both 
peptidomimetics labeled at the same positions reveal d no difference in the spectra between 
and upon photoswitching. The spectra of the doubly-labeled α/α-model peptides contained 
one pair of the 19F-NMR signals confirming that the two identical α-helical parts are 
structured and aligned in the bilayer similarly. This is what could be expected assuming that 
the open-ring conformationally flexible DAET residue in these peptidomimetics allows 
virtually autonomous interaction of the BP100 units with the lipid membrane. Even in the 
gel-phase lipids the open-ring DAET fragment should permit independent alignment of the 
BP100 helices in both cases. Notably, the parent BP100 peptide which was shown to be 
aligned in the S-state in the bilayer (with the helix axis parallel to the membrane plane), was 
found extremely mobile. The fact that the model peptid s studied here are approximately 
double the size of the BP100 and nevertheless revealed similar 19F-NMR signal patterns 
challenged the suggestion that only the small size i  the reason of the high BP100 mobility. It 
should also be noted that BP100 units in both peptidom metics studied here, on the contrary 
to the parent peptide, do not have the N-terminal amino group, protonated under the 
conditions used. Still, all the spectra are very similar, suggesting that similar helix alignments 
for BP100 with a reduced net charge. The fact could not be attributed to any special 
membrane-attraction to the aromatic DAET moiety, since more hydrophobic open-ring 
DAET fragment brings no difference to the membrane-bound orientation of the BP100 unit. 
Contrasting the influence of the latter DAET state to the first adjacent residue of a β-strand 
(Figure 3.7.) and apparent β-breaking potential, for α-helix edges open-ring DAET 
photoswitches appeared to be almost non-perturbing. 
The closed-ring photoswitches seemed to be more structurally perturbing for the 
helical fragments in the studied peptidomimetics. A highlighted in the Figure 3.10., the 
doubly-labeled α/α-model peptides gave very complex 19F-NMR spectra in the gel-phase 
bilayers. In each case about a half of the spectral intensity corresponds to the gel-state spectra 
of the β/α-model peptides and of the wild type BP100. This could be due to symmetric 
structure of the α/α-model, where one BP100 unit will align as expected for BP100. The 
second unit in the α/α-model is influenced by perturbance from the rigid planar closed-ring 
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DAET moiety in the low viscous environment of the gl-state lipids and has no chance to 
adapt to the same orientation. Since no similar observation was made with the β/α-model, 
such constraint should apply only to helical fragments, or restricted position is compatible to 
the native orientation of the β-strand.  
In line with the above observation, the only observed difference to the dipolar splitting 
pattern in the β/α-model spectra was recorded for the Leu3 position in the gel-state bilayers, 
i.e., for the β/α-3L analogue.  The value of -7.5 kHz splitting, however, is very close to the 
signal expected for the powder, i.e. for the non-oriented immobilized CF3-labelled peptide. It 
might mean that the perturbation sphere of the backbone-incorporated SwI unit does not 
exceed three adjacent residues.  
Since significant conformational changes of the peptidomimetic molecules were 
observed only in the gel-phase lipids and not in the liquid-phase bilayers or in the CD spectra, 
one might conclude that the SwI unit photoswitching induces only minor conformational 
perturbation of the peptides under study. This means that the unit could be easily 
accommodated in the peptides and its impact on the linear peptide structure and function is 
minimal. In other words, photoswitching of DAET fragment may be too weak to induce 
strong structural effects in the middle of a linear peptide. From the other hand, this 
conclusion might not be true for cyclic peptides or hairpin-like folds, which could be 
structurally perturbed by Sw-like photoswitching to much higher extent.   
 
 
3.3. Photoswitchable analogues of the antimicrobial peptide GS with the SwI building 
block 
 
Gramicidin S (GS) photoswitchable analogues were prepared to explore the DAET 
building block SwI in a cyclic peptide context, and to investigate th possibility of controlling 
a peptide functional activity with light. First, GS modification with the SwI fragment was 
performed.  
GS is a small natural peptide with a range of biological activities, including 
antimicrobial, hemolytic and antifungal. It has a peculiar symmetric structure: two identical 
peptidyl fragments are conjugated with each other to form the cyclo(PVOLDF-PVOLDF) 
sequence. The secondary structure of GS is characterized by two parallel short β-strands (-
Val-Orn-Leu-) that are constrained from both sides with two type II' β-turns (-Leu-DPhe-Pro-
Val). GS is well characterized; relationship of its s ructural features and observed biological 
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activities is well-established125. This knowledge gives a basis for rational design of DAET-
containing GS derivatives. 
Two main features are known to be of particular importance for the GS antibacterial 
activity: the presence of positively charged ornithi e residues and the overall amphiphilic 
character of the peptide (its “sidedness”)126. Obviously, the design of the photoswitchable 
analogues must leave this feature intact. Therefore, modifications of both β-turns fragments (-
Leu-DPhe-Pro-Val-) seems logical127,128, and in order to obey the amphiphilicity requirement, 
substitutions with a non-polar moiety (like the residue of SwI) could be done in any of the 
two segments. As follows from simple molecular modeling129, the size of the SwI fragment 
approximately corresponds to two amino acid residues. In order to empirically find the 
optimal site for the GS β-turn modification with the SwI, different dipeptidyl substitutions 
were done. The SwI residue was exchanged for three different pairs of the amino acid residues 




Scheme 3.11. Cyclic gramicidin S (GS) and its designed photoswitchable analogues. GS-
SwI(LF) denotes peptidomimetic with substituted leucine a d phenylalanine residues by the 
SwI fragment, GS-SwI(FP) represents the replacement of phenylalanine and proline residues, 




3.3.1. Synthesis of GS analogues  
 
The synthesis of GS analogues was based on the previously published protocol which 
included construction of linear precursors by SPPS, followed by an intramolecular cyclization 
in solution130. However the method was substantially modified during the implementation, as 
described in Chapter 6.2.3. The amino acid sequences of the synthesized peptidomimetics are 
shown in Table 3.6.  
As in the case of synthesis of linear peptidomimetics (Chapter 3.2.1.), construction of 
linear sequences proceeded without problems, the Fmoc-SwI building block was compatible 
to the Fmoc-SPPS. A major problematic step was found to be the head-to-tail cyclization of 
the linear precursors. The prevailing process which led to low yields of final GS analogues 
was intermolecular polycondensation as confirmed by MALDI. This side reaction is known 
to obscure cyclization when the linear fragments are st ucturally not well preorganized in 
solution130. Indeed, the non-modified GS (the wild type) can be synthesized with almost 
quantitative yield at the cyclization step when thepr organization is ensured130. Performed 
under the same conditions, the cyclization of the GS analogues proceeded with markedly 
lower efficiency (20-30%, as analyzed by RP-HPLC). This result points to potential 
perturbation of the GS backbone by the building block SwI, so the linear peptides apparently 
have different conformation, unfavorable for the cyclization process and are less well 
preorganized compared to the wild type sequence. 
 
Table 3.6. Amino acid sequences of gramicidin S and its photoswitchable analogues. 





* SwI denotes the residue of the building block 31. 
 
Nevertheless, pure GS analogues were obtained after two-step RP-HPLC purification 
(Chapter 6.2.3.). First, a preparative column was used to separate the products from the main 
impurities. Next, on a semi-preparative HPLC column, the purity of the peptides was 
increased to>95%. As will be discussed below, the potoconversion of the GS open-ring 
analogues to the closed-ring forms proceeded with 20-80% efficiency, mostly depending on 
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the solvent. Therefore, chromatographic separation was used to obtain pure closed-ring forms 
for all three GS analogues. 
 
3.3.2. Photochromic properties of the GS analogues  
 
After completion of the synthesis and successful purification of the SwI-modified GS 
analogues, their basic photochromic properties were studied. The solutions containing the 
peptidomimetics in 100 µg/ml concentration were exposed to either UV or visible light for 
different intervals of time. The process of converting from one form to the other was 
monitored by an analytical RP-HPLC (Figure 3.12.). It turned out that the photoconversion of 
peptides from the open-ring to the closed-ring form did not proceed completely even after 
prolonged exposure to UV light. Addition of a denaturizing (chaotropic) agent to the peptide 
solutions significantly increased the yield of the photogenerated closed-ring forms. This 
observation can be explained assuming structural featur s of GS. The structure of the parent 
peptide is additionally stabilized by four intramolecular hydrogen bonds. Presumably, similar 
hydrogen bonds prevent the GS analogues from adopting conformations suitable for the 
conversion into the closed-ring form, but they could be broken by denaturizing agents. 
 
 
Figure 3.12. (a) Analytical RP-HPLC chromatograms of GS-SwI(FP) at 100 µg/ml in water, 
recorded during the course of illumination with UV light, and with visible light. The peak at 
10 min retention time corresponds to the open-ring form; two peaks at around 8 min are two 
diastereomeric isomers of closed-ring form. (b) Two diastereomers (R,R and S,S 




It is known (Chapter 1.2.5.) that the photocyclization reaction of DAETs can proceed 
only from the antiparallel conformation. If the molecule is artificially fixed in the parallel 
conformation, for instance through structuring of the peptidic unit in the GS analogues, the 
yield of the photoconversion declines (Figure 3.13.). The closed-ring forms of the GS 
analogues were found to be thermally stabile and could be stored for a long time without any 
detectable conversion to the open-ring photoforms, unless the visible light is applied. 
It should be noted that the closed-ring forms of DAETs exist as two diastereomeric 
isomers131 with R,R- or S,S-configurations at the two chiral c rbon atoms. The two isomers 
of the closed-ring form were possible to distinguish in some cases by analytical RP-HPLC 
(Figure 3.12a.). Although the diastereomers might have different physical and chemical 
properties, they were not separated in this study and were used for functional tests as 
mixtures. 
The reverse photoisomerization of GS analogues from c lored closed-ring forms to 
the initial colorless forms was also evaluated. In this case, 100% conversion could be 





Figure 3.13. Kinetics of the photoconversion of GS analogues under different conditions: (a, 
b) from the open-ring forms to the closed-ring forms by irradiation with UV light at 25°C, 
100 µg/ml solution in a water-acetonitrile mixture, 3:1 v/v (a); in 1 M aqueous urea (b); For 
GS-SwI(FP) from the closed-ring to the open-ring form by irradiation with visible light in a 





3.3.3. Hydrophobicity of the GS analogues 
 
Hydrophobic and amphiphilic characteristics are critical parameters for many 
membrane-active peptides including GS. The changes in the hydrophobicity of small peptides 
could be monitored with the RP-HPLC as it correlates with their retention times (RT)132. For 
example, substitution of an L-amino with a D-amino acid in the GS and its derivatives caused 
significant decrease of the amphiphilicity which manifested as pronounced reduction of the 
RT values133. 
To characterize hydrophobic properties of the GS analogues, the elution profiles of the 
peptidomimetics (see Chapter 3.3.1) were studied in both photoforms and were compared to 
the wild type GS (Figure 3.14.). The longest RT, which corresponds to the highest 
hydrophobicity, was found for the GS wild type. All three GS analogues in their open-ring 
forms eluted with RTs of about 10 minutes. The RT values increased in the following 
sequence: GS-SwI(LF) < GS-SwI(FP) ≈ GS-SwI(PV) < GS.  
 
 
Figure 3.14. Analytical RP-HPLC elution profile (a) of the GS wild type, and its 
photoswitchable analogues (b) GS-SwI(LF), (c) GS-SwI(FP), and (d) GS-SwI(PV), each in the 
open-ring (black) and closed-ring form (red). (Conditions see in Chapter 6.). 
 
Photoconversion of the peptides to their closed-ring forms led to decrease of the RTs with the 
order being maintained. The pairs of diastereomers (discussed in the previous chapter) of 
closed-ring forms were found to have almost equal RTs, as expected. This result suggests that 
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the open-ring forms are similar to the wild type GSin terms of the hydrophobicity, and the 
corresponding closed-ring analogues are more polar. Interestingly, of photoswitchable 
peptides (Chapters 3.1 and 3.2) similar but much less pronounced effect was observed in the 
linear models, that was presumably a result of different intrinsic polarity of the two 
photoforms of the DAET unit.  
 
3.3.4. Circular dichroism analysis of GS analogues 
 
CD spectra of the peptidomimetics were measured in order to estimate the changes in 
secondary structures upon the photoisomerization of the DAET unit. The CD spectra in 
phosphate buffer were of low quality due to poor water solubility of the wild type GS and the 
analogues. Successful measurements were done in membrane-mimicking environments, 
namely, in 50% trifluoroethanol (TFE) and in detergent micelles (SDS, 25 mM). The 
peptidomimetics were studied in their both photoforms using the following procedure. The 
CD spectra of the closed-ring forms were measured fi st. Next, the samples were exposed to 
visible light for time periods needed to convert 100% of the peptidomimetics into the 
colorless open-ring forms (visual control), and the second set of the CD spectra was recorded. 
The control experiments performed with wild type GS showed no effect of light on the 
sample quality or any radiation damage. The obtained CD spectra are collected in Figure 
3.15. 
Cyclic structure and the presence of D-amino acids in GS prevented precise secondary 
structure assessment by deconvolution of the CD signals134. Furthermore, extraction of the 
structural information from the CD lineshapes was also complicated by the presence of the 
DAET moiety. The diarylethene unit is itself a chrom phore and gives photoform-dependent 
CD signal, which extends to the long-wavelength range useful for peptide secondary structure 
estimation135. Due to these reasons, the CD spectra of the GS analogues were only compared 
with the GS wild type spectra for some qualitative assessments.  
The CD spectra of the open-ring forms of GS-SwI(LF) and GS-SwI(FP) in TFE were 
similar to the wild-type GS spectra, with non-resolved negative bands at ca. 210 and 220 nm. 
The peptidomimetic GS-SwI(PV) spectra also had the same negative bands, resolved better, 
at ca. 220 and 200 nm. This peptidomimetic showed essentially the same spectrum in the 
180-260 nm spectral window after the photoconversion, only the intensity of the signals 
increased. On the contrary, the GS-SwI(LF) and GS-SwI(FP) converted to the closed-ring 
form gave the essentially different CD spectra, with the lineshapes similar to that of the GS-
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SwI(PV) analogue, suggesting structural similarity for all the three closed-ring 
peptidomimetics.  
The presence of detergent micelles did not affected th  wild type GS CD spectra, as 
could be expected from the stability of the hydrogen bond-stabilized fold of the peptide. The 
CD spectra of the GS analogues in the open-ring form did change as a consequence of 
conformational changes upon micelle binding. The band t ca. 220 pronounced most strongly 
and the low wavelength signal (ca. 210) converted into a shoulder. Interestingly, in the 
closed-ring states all three peptidomimetics revealed very similar signal shapes below 260 
nm, resembling signals observed for them in TFE.  
Irrespective of the conditions, the main negative CD bands in the spectra of the 
closed-ring form peptidomimetics appeared systematically shifted towards lower 
wavelengths, i.e. towards more “random coil”-like lineshape with a pronounced minimum at 
~200 nm. Such spectra resembling that of the unfolded polypeptides may indicate less order 
for the peptidomimetic backbones. This interpretation of the CD spectra of the closed-ring 
peptidomimetics will explain also their similarity which was noted above. Under both 
membrane-mimicking conditions measured, the spectra thus reflected stiffer and much less 
structured conformations as compared with GS wild type. The spectra of the open-ring forms, 
on the other hand, differed between the two membrane-mimicking environments, which 
supports higher flexibility of the molecular backbones expected for these photoforms. Under 
both conditions, the open-ring molecules clearly exhibit “non-random” CD signals. For one 
of the conformations (in 50% TFE) the CD lineshape resembled that of GS (with a 
pronounced minimum at ~210, and a lower minimum at ~220 nm). As was discussed above, 
RP-HPLC analysis (Chapter 3.3.3.) had shown that the perturbation of the backbone 
conformation by the photoswitch in the open-ring forms most likely lead to a lesser 
perturbance in the amphiphilicity of the molecules than in the closed-ring form. Notably, TFE 
solution is the only condition when open-ring forms of the GS analogues appeared to have 
the structure close to that of the wild type peptide. TFE is a special solvent with regard to its 
interaction with membrane-active peptides. On the on  hand, it has the same dielectric 
constant as the bilayer interface (ε ~20) and is therefore a good mimic of the membrane 
surface. On the other hand, TFE is known for its structuring effects on the polypeptides – it is 
often nodded as a solvent which “artificially” promtes α-helical fold. The latter observation 
provides ambiguity to the interpretations of peptide structures in TFE – the conformations 
may be artificially driven. In the case of GS analogues this α-helix promoting action of TFE 
could be excluded, because these small peptides due to th ir cyclic structure simply cannot 
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fold as an α-helix. Therefore observed similarity between GS structure and the structures of 
the open-ring forms of the photoswitchable analogues in TFE rather suggest the flexible 
analogues to be able to fold as GS at conditions of membrane interface. The SDS data reveals 
much less structural similarity to the wild type GS, even for the open-ring forms. Perhaps in 
this case SDS membrane model is less representative of the biomembranes, e.g. in that the 
negatively charged detergent headgroups are sulfates. Sulfate headgroups may interact 
strongly with the aromatic system of the DAET cores, and this impact may be stronger than 
the fold-promoting influence onto peptidylic parts of the molecules.  
 
 
Figure 3.15. Circular dichroism spectra of GS (black dashed line) and each of the three 
analogues in the open-ring (black line) and closed-ring (red line) forms measured at (a, b, c) 
a concentration 75 µg/ml, at 25°C, in 50 vol% TFE; (d, e, f) in SDS micelles, with a 
peptide:detergent molar ratio of 1:25. (a, d) GS-SwI(LF); (b, e) GS-SwI(FP); and (c, f) GS-
SwI(PV). 
For one of the peptidomimetics more detailed investigation was undertaken. Two 
diastereomers of the closed-ring form of GS-SwI(FP) were isolated with RP-HPLC and each 
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diastereomer was studied individually by the CD spectroscopy (Figure3.16.). This study 
should get better insight into the CD signature of the DAET unit. Since no steric assignment 
was done, the isomers were named isomer 1 (shorter RT) and isomer 2 (longer RT). The 
obtained CD spectra (Figure 3.16.) of the both isomers gave similar negative bands at short 
wavelength (~200 nm), however there was significant difference at longer wavelengths. In 
particular, strong positive band for the isomer 1 and  mirrored negative signal for the isomer 
2 were observed at 360 nm. This wavelength corresponds to the absorption band of closed-
ring form of DAET (Chapter 3.1.1.). However, there was no signal in the CD spectra at the 
second absorption region around 560 nm. The value of CD signal at this wavelength could be 
used to identify the diastereomer configuration of any DAET modified peptidomimetics if the 
positive and negative values are assigned to particular diastereomers.  
Preparative separation of isomers of the closed-ring form was possible only for the 
peptide GS-SwI(FP). Other GS analogues had too close RTs to be separat d by RP-HPLC.  
 
 
Figure 3.16. Circular dichroism spectra of the peptides GS-SwI(FP) closed-ring form 
diastereomers measured at a concentration 125 µg/ml, at 25°C, in SDS micelles, with a 
peptide:detergent molar ratio of 1:25. Blue line corresponds to isomer 1, red to isomer 2. 
 
3.3.5. Antimicrobial activity of GS analogues 
 
Since GS is a well characterized peptide antibacteri l agent, the studies performed 
here were focused on answering three main questions. First, it was important to check if the 
diarylethene-modified GS analogues had any antimicrob al activity. If so, it was interesting to 
learn whether bacterial selectivity (action against Gram-negative vs. Gram-positive strains) 
for the new GS analogues was preserved. Finally, the most interesting question was if there 
were any differences in antibacterial activities between the open- and the closed-ring forms.  
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The antimicrobial activities of the photoswitchable GS analogues in both photoforms 
were tested by means of broth dilution assays. These assays were performed against 
planktonic forms of bacteria and are expressed as minimum inhibitory concentrations (MICs) 
needed to prevent growth of bacterial culture (see details in Chapter 6.5.). 
The stock solutions of the peptidomimetics in the op n- and closed-ring forms were 
prepared in advance and all the precautions were made to maintain the photophorms of the 
peptidomimetics intact during all the experiments. The MIC values obtained for GS-SwI(LF) 
GS-SwI(FP) are summarized in Table 3.7. As can be seen, the GS analogues possess the 
antibacterial activity similar to that of the parent antibiotic GS. Like the GS wild type, the 
photoswitchable analogues showed low activity against Gram-negative bacteria, but remained 
active against Gram-positive strains. There was no ignificant difference in performance of 
the two tested peptidomimetics, and the closed-ring forms showed lower activity against 
tested bacteria. 
 
Table 3.7. Antimicrobial activity of GS and its photoswitchable analogues tested against 
Gram-positive and Gram-negative bacteria strains. 
 
Bacterium 
MIC (µg /ml) 
GS GS-SwI(LF) GS-SwI(FP) 
  open-ring closed-ring open-ring closed-ring 
E. coli 32 128 256 64 >256 
S. aureus 2 8 16 8 64 
B. subtilis 1 4 8 4 32 
S. typhimurium 128 >256 >256 128 >256 
 
The antimicrobial activity assays were repeated for all three peptidomimetics with 
focusing on the precise evaluation of the differences between the open-ring and closed-ring 
forms. For this study three Gram-positive strains: S. aureus, S. epidermidis and S. xylosus 
were selected. The initial concentrations of the opn- and closed-ring forms were 128 and 256 
µg/ml, respectively. In order to decrease the systema ic error in setting the concentrations, the 
initial stock solutions (prepared gravimetrically) were corrected. For this purpose, accurate 
RP-HPLC calibration curve was established and the concentration in the initial stock 
solutions was determined. The second set of solutions was prepared by dilution. 
Antimicrobial activity determinations were performed under dim light to prevent the visible 
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light-induced DAET ring-opening of the peptides in their closed-ring photoforms. The results 
(Table 3.8.) clearly showed that the antimicrobial activity of the GS analogues persisted and 
indeed can be controlled by light. All three peptides in the open-ring forms exhibited high 
antimicrobial activity, being almost as active as GS itself. The analogues in the closed-ring 
form were distinctly less active than in the open-ring forms on all bacterial strains tested. The 
biggest differences were observed for the peptide GS-SwI(LF). In the more active open-ring 
from against S. aureus the peptide showed MIC of 8 µg/ml while in the lesser active close-
ring form the activity was four dilutions smaller (MIC equal 128 µg/ml). 
 
Table 3.8. Antimicrobial activities of GS and of its photoswitchable analogues tested on 
Gram-positive bacteria strains. 
 
Bacterium 
MIC (µg /ml) 
GS GS-SwI(LF) GS-SwI(FP) GS-SwI(PV) 
     open*  closed* *    open* closed* * open* closed* * 
S. aureus 2 8 128 4 32 4 16 
S. epidermidis 2 16 128 8 64 4 32 
S. xylosus 1 8 128 8 32 4 32 
* refer to open-ring form; **  refer to closed-ring form. 
 
3.3.6. Visualization of the antimicrobial activity of GS analogues 
 
As was shown in the above antimicrobial studies (Chapter 3.3.5.) for all three GS 
analogues it was possible to define a therapeutically important concentration range in which 
the photoswitchable peptides in the open-ring forms suppressed bacterial growth, while being 
inactive in the closed-ring forms.  
The ability to control antimicrobial activity with light could find an application in 
medicine, e.g. in photodynamic therapy8. The above experiments were performed using 
isolated GS analogues in either open-ring or closed-ring forms. As a proof-of-principle study, 
demonstration of the functional in situ photocontrol was performed. The peptide GS-SwI(FP) 
was selected for the validation. The experiments were performed with bacteria growing on 
solid media. To the growth medium of the agar inoculated with S. xylosis the peptidomimetic 
was added in the least active closed-ring form. Then s lected areas on the Petri dish were 
irradiated with the visible light through a mask. This allowed activating the peptidomimetic 
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through photoconversion to the open-ring form in a sp tially-controlled fashion. Finally, the 
plates were incubated and inspected for the presenc of bacterial colonies as usually done in 
agar-diffusion antimicrobial tests (see Chapter 6.6. for details). 
In order to determine the optimal conditions different concentrations of the 
deactivated peptidomimetic and different times of illumination were tested (Figure 3.17.). 




Figure 3.17. Antimicrobial effect of the photoswitchable peptidomimetic GS-SwI(FP) on S. 
xylosus. The GS analogue in the closed-ring form was applied to agar medium together with 
bacterial cells and irradiated with visible light through a mask. Applied (a) at 6 µg/ml in the 
closed-ring form followed by 9 min exposure to visible light that corresponds to 60% 
conversion to active open-ring form (as calculated from the curve in Figure 3.13c.); (b) at 6 
µg/ml, conversion 80% in 16 min; (c) 8 µg/ml, conversion 60% in 9 min; (d) 8 µg/ml, 
conversion 80% in 16 min. 
 
The optimal conditions were found to be the following: application of the 
peptidomimetic at the concentration 8 µg/ml followed by illumination with visible light for 
16 min (estimated to reach 80% conversion, see Chapter 3.3.2.) which should correspond to 
generation of 6.4 µg/ml of the more active closed-ring form. It has to be noted that in neither 
experiment intermediate levels of activity were observed rendering in situ photocontrol as 
discrete switching-on/switching-off process. 
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Results of the demonstration experiment are shown in Figure 3.18., where an image of 
Mona Lisa was used as the mask. 
 
 
Figure 3.18. Demonstration of the photoswitchable properties of the peptidomimetic GS-
SwI(FP) on the agar-grown S. xylosus. (a) Corresponds to the open-ring form generated 
during the course of irradiation with visible light. (b) Corresponds to the peptidomimetic in 
less active closed-ring from below MIC. 
 
3.3.7. Hemolytic activity of GS analogues  
 
Besides antimicrobial activity, hemolysis is another important characteristic that has 
to be considered during practical applications of antimicrobial peptides136. To be useful as 
antimicrobial agent for treatment different infections in humans, an antibiotic must 
demonstrate selective toxicity between mammalian and microbial cells. It has to be noted that 
for GS the hemolytic side effect is a major problem associated with its clinical application137.  
Hemolytic activity of the GS analogues was characterized by determination of their 
HC50 values (the concentrations required for 50% hemolysis of erythrocytes) according to the 
protocol described in Chapter 6.7. The obtained dependences of the hemolysis on the 
peptidomimetic concentrations are shown in Figure 3.19. The HC50 values determined from 
these graphs are listed in Table 3.9. Smaller HC50 values indicate higher hemolytic activity, 
and vice versa. The results showed that in the open-ring forms the p otoswitchable analogues 
retained high hemolytic activities similar to GS wild type. While in the rigidified closed-ring 





Figure 3.19. Concentration-dependent lysis of the red blood cells. GS (black dashed line) is 
compared to its analogues in the open-ring (black line) and closed-ring (red line) forms. (a) 
GS-SwI(LF), (b) GS-SwI(FP), and (c) GS-SwI(PV). 
 
The ratio between HC50 and MIC values defines a therapeutic window at which the 
agent can be applied without harmful effect to an organism. Thus the photocontrol of the 
hemolytic activity of antimicrobial agents, as was demonstrated above, is opening a way for 
their applying in areas where it was not possible before due to the toxic side-effects. 
 
Table 3.9. HC50 values for GS and for its photoswitchable analogues observed as 50% lysis 
of human erythrocytes compared to the action of 0.1% Triton X-100. 
 
Peptides 
GS GS-SwI(LF) GS-SwI(FP) GS-SwI(PV) 
  open*  closed**  open closed open closed 
HC50 (µg/ml) 12 47 >>128 6.5 72 6 58 









3.4. Photoswitchable analogues of the antimicrobial peptide GS with the SwII  building 
block 
 
After successful demonstration of the photocontrol of the antimicrobial activity, a new 
more ambitious aim was set – to demonstrate photocon rol of an anticancer activity of the 
DAET-modified peptidomimetics. As for antibacterial ctivity, gramicidin S appeared as 
suitable template for such a purpose. GS was reportd to possess high cytotoxic activity 
against both bacteria and eukaryotic cells138,139. It was shown to have prospects for 
application in cancer therapy138. In these in vivo experiments performed on a mouse model, 
daily intraperitoneal injections of 20-200 µg of GS per mice per day showed strong inhibitory 
effect on the growth of implanted tumors. However, GS simultaneously revealed high 
systemic toxicity and thus could not be applied for cancer therapy in unmodified form. The 
photoswitchable properties of GS analogues can helpto eliminate the problem of high 
toxicity. 
In the course of evaluation of the antimicrobial activity of the GS analogues 
containing DAET building block 31 (described in Chapter 3.3.) several drawbacks were 
identified. Major problem was found to be the overall low yields during peptidomimetic 
synthesis, particularly due to difficulties at the step of head-to-tail cyclization. Moreover, 
initially obtained amounts of GS analogues with theDAET switching unit SwI (dozens of 
milligrams) were enough to carry CD structural analyses and to measure antimicrobial and 
hemolytic activities in the in vitro assays. For anticancer activity tests, on the contrary, a 
broad study involving cell-based assays and tests on animal models was planned. These 
experiments required larger amounts of peptidomimetic material (in the range of 500 mg). 
Due to these reasons the approach for synthesis of photoswitchable peptidomimetics based on 
GS was modified through introduction of the new DAET-derivatives, the SwII (see Chapter 
3.1.2). The new building blocks contained a canonical amino acid proline residue bearing the 
terminal amino group (L-enantiomer in 39 and of D-enantiomer in 40). 
As was mentioned above, synthesis of cyclic peptidom metics with the hydrazide-
containing building block SwI faced with several synthetic problems. Mass-spectros opy 
analysis revealed that large amounts of linear peptid s terminated at SwI position is forming 
during cyclisation step as the by-products (see the discussion in Chapter 3.3.1.). Therefore, 
several attempts were done to improve the yields of the cyclization step leading to cyclic SwI-
modified GS analogues. In the original protocol of the GS-SwI(FP) synthesis the sequence 
[H-DFPVOL-SwI-VOL-OH] was used as a linear peptide precursor. Hee, the DAET unit was 
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placed in the middle of the peptide chain in analogy to the linear model peptides, which were 
produced in good yields (Chapter 3.2.1.). Assuming that the sequence of the linear peptide 
(e.g. the starting position) prior to cyclization determines its preorganization in solution130  
one might suggest, that the SwI unit may hinder achieving the conformation of the linear 
precursor favorable to the cyclization, and therefore limit its. To test this hypothesis, the 
position of SwI unit was shifted to the N-terminus. The shift, however, decreased the 
cyclisation yield due to the above mentioned chemical instability of the hydrazide connection 
and other multiple side-reactions occurred. Notably, the side-products were not the result of 
the polycondensation reaction, as was observed with the SwI in the middle of the sequence. 
Moreover, the undesired chemical transformations occurred exclusively at the 
macrocyclization step. Therefore, the DAET amino acid analogues were redesigned, 
providing the second-generation building blocks containing SwII fragments (see Chapter 
3.1.2. for structures and synthesis). 
The second-generation building blocks were used for further optimization of the GS 
photoswitchable peptides. Anticancer activity tests were performed on a GS analogue 
possessing the DAET unit in place of the of the phenylalanine and proline, residues in the 
wild-type molecule, as in GS-SwI(FP) (Chapter 3.3.). The peptidomimetic GS-SwI(FP) was 
selected as the lead because it demonstrated the larg st change in retention times on 
analytical RP-HPLC between the two photoforms, among all the tested GS analogues. The 
only chemical modification to this lead was the useof the second-generation DAET building 
blocks. Since SwII exists in two enantiomeric forms, two peptidomimetics were obtained. The 
corresponding amino acid sequence of these peptidomimetics was cyclo(DFPVOL-SwXPro-
VOL) where SwXPro is either a residue of the building block 39 (SwLPro) or of 40 (SwDPro). 
The structure of these two peptidomimetic is shown in Figure 3.20. 
 
3.4.1. Synthesis of GS analogues  
 
In order to synthesize new photoswitchable GS analogues and upscale the synthesis 
the synthetic method described in Chapter 6.2.3 was further modified. In the new method for 
construction of the linear peptides the sequences [H-SwXPro-VOLDFPVOL-OH] were used. 
The DAET unit was the last amino acid to be coupled in SPPS which reduced the exposure to 
the coupling-deprotection reagents and helped in maintaining the structural preorganization 
of the linear peptide favorable for the head-to-tail cyclization (see the discussion above). 
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Gratifyingly, the cyclisation reactions proceeded in excellent yields (>80%, as 
analyzed by RP-HPLC) and no side-product formation was detected. However, the building 
blocks 39 and 40 were available as racemic mixtures as proline residue partially 
enantiomerised during the synthesis (80:20 in one cas  and 60:40 in another). The target GS-
analogues were nevertheless possible to separate using preparative RP-HPLC. The known 
enantiomeric excess was used to identify the final peptide products. 
The RP-HPLC elution profiles of the new GS analogues are shown in the Figure 3.21. 
Two studied peptides showed very close RTs suggesting that they have similar physical and 
chemical properties. GS-SwLPro(FP) had slightly longer RTs (around 1 min on a 
chromatogram with a gradient slope of 1% solvent B/min). Interestingly, the RT values of 
both analogues in the open-ring forms were close to that of the wild type GS, while first-
generation analogue GS-SwI(FP) eluted much earlier (Chapter 3.3.3). This difference can be 
explained by the increase of the peptide hydrophobicity after the introduction of the proline 
residue instead of the polar hydrazide group. It can also be a result of smaller perturbations of 
native amphipathic structure with the new building block SwII. The photoconversion to the 
closed-ring forms have resulted in significant decrease in RT (16 min using the gradient 
above), similar to all the GS analogues studied so far possessing the building block SwI. 
Substantial amounts of peptidomimetics were synthesized and purified: 100 mg of 
peptidomimetic GS-SwLPro(FP) and 25 mg of GS-SwDPro(FP). 
 
 
Figure 3.20. Structure of the GS analogues containing second-generation DAET building 
blocks SwII (shown in red). Two amino acids (Phe and Pro) substituted in the native GS 











Figure 3.21. Analytical RP-HPLC elution profiles (a) of the GS wild type, and its 
photoswitchable analogues (b) GS-SwDPro(FP), (c) GS-SwLPro(FP), each in the open-ring 
(black) and closed-ring forms (red). (Conditions see in Chapter 6.). 
 
3.4.2. Anticancer activity of GS analogues  
 
The cytotoxic activity of the peptidomimetic GS-SwLPro(FP) was studied in order to 
access the potency of the new photoswitchable GS analogues in cancer therapy. To this aim, 
the cytotoxicity of the peptidomimetic in both photoforms was measured employing a 
standard MTT assay (see details in the Chapter 6.8.). Two cancer cell lines were used: cervix 
cancer line HeLa and hepatocellular carcinoma G2. The same way as it was in the study of 
antibacterial activity, the peptidomimetic forms with the open-ring and closed-ring DAET 
states were prepared before the tests using preparative HPLC and all the experiments were 
performed under dim light conditions to prevent uncontrolled photoisomerization of the 
peptidomimetic. 
The viabilities of the cells at different concentrations of the peptidomimetic are shown 
in Figure 3.22. It can be seen that the open-ring form of GS-SwLPro(FP) demonstrated 
significant cytotoxicity against both cell lines, with calculated IC50 about 12 µg/ml against 
cancer line HeLa and 24 µg/ml against hepatocellular carcinoma G2. Deactivated closed-ring 
from of the peptidomimetic showed much lower cytotoxicity against both cell lines. No 
cytotoxicity was observed in the experiments with hepatocellular carcinoma G2: the closed-
ring form was active only at the highest tested concentration of 64 µg/ml. Since no further 
concentrations were employed, in both cases the IC50 was assigned as > 64 µg/ml. These 






Figure 3.22. The cytotoxic activity of the photoswitchable analogue GS-SwLPro(FP) in both 
open-ring and closed-ring forms measured in the MTT test (a) against cervix cancer line 
HeLa, (b) against hepatocellular carcinoma G2 cancer line.  
 
3.5. Photocontrolled fluorescent cell imaging with DAET containing peptides 
 
As was discussed in Chapter 1.3., diarylethenes possess intrinsic fluorescent 
properties. Moreover, their fluorescence depends on the photoform. The DAET derivatives 
that were used in this study are dithienylcyclopentenes with two carbonyl groups at 2- and 2'-
positions and produce fluorescent signal in the open-ring photoforms. In particular, the 
fluorescent properties of the building block 31 in water environment were studied using small 
peptidic derivative, as described in Chapter 3.1.1. Chapters 3.3. and 3.4. above describe 
photoswitchable analogues of the antimicrobial peptid  gramicidin S. 
In order to better understand the mechanism of action and distribution of the 
gramicidin S in living bacterial cells, one of the DAET-containing GS derivatives was used as 
a fluorescent probe. GS is a small and sensitive to modifications peptide. Its fluorescent 
labeling is problematic due to the fact that attachment of any large hydrophobic fluorophore 
will dramatically change its amphiphilic character, and, as a result, its biologically relevant 
interaction with the lipid bilayer. On the other hand, the DAET-modified GS analogues 
already have a built-in fluorescent label and thus can be used as a fluorescent probes. 
Showing similar spectrum of activities to the wild type peptide and comparable structural 
features, these analogues may have similar mode of binding to membranes and similar 
mechanism of action. The fluorescent properties of GS photoswitchable analogues were used 
in the following experiment: the bacteria cells of Bacillus subtilis and Kocuria rhizophola 
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strains were treated for 1 hour with GS-SwI(FP) at 100 µg/ml concentration in the open-ring 
form. Then the distribution of the fluorescent GS analogue was recorded as shown in Figure 
3.23 (microscope Axioskop 40 was used). Green and week red fluorescence of the 
peptidomimetic in open-ring form was observed. In experiments with both bacterial strains 
the peptidomimetic not only bound to the cell membrane, but also appeared translocating 
inside the cells. Interestingly, most intense signal i side the cells was detected in the 
cytoplasm which suggests that the peptidomimetic was absorbed by the inner membrane. The 




Figure 3.23. Fluorescent cell staining with peptidomimetic GS-SwI(FP) at 100 µg/ml in open-
ring form. (a) green fluorescence of Bacillus subtilis, (b) and (c) green fluorescence of 
Kocuria rhizophola, (d) red fluorescence of Kocuria hizophola; (a), (b) and (c) emission at 
450-490 nm, (d) emission at 546 nm. 
 
In the other set of experiments a possibility of dynamic photocontrol of the 
fluorescence in bacterial culture was demonstrated. The possibility to reversibly switch off 
and on the fluorescence in bioimaging is very useful since it allows increasing the contrast by 
subtracting the background fluorescence57. This approach was demonstrated with the 
photoswitchable GS analogue GS-SwI(FP) as shown in Figure 3.24. First, a group of bacteria 
was identified under white light as shown in the panel (a). The same cell cluster was left 
under the UV light for 5 min to convert the peptidomimetic into the closed-ring form, which 
resulted in turning the fluorescence off (panel b). The visible light was then applied for 5 min 
to convert the GS analogue back to the fluorescent open-form (panel c). Finally, the 







Figure 3.24. Fluorescent cell staining by GS photoswitchable analogue GS-SwI(FP). Kocuria 
rhizophola treated for 1 hour with 100 µg/ml of peptidomimetic GS-SwI(FP) in closed-ring 
form, emission at 450-490 nm. (a) White light microph tograph. (b), (c), (d) Illustration of 
the photoswitching between fluorescent and non-fluorescent states: (b) the fluorescence is 
absent, peptidomimetic is in the closed-ring form, (c) the fluorescence raised after 
photoconversion to the open-ring form by visible light, (d) the fluorescence decayed after 
irradiation with UV light. 
 
3.6. Photoswitchable analogues of the anticancer petide SVS-1 with the SwII  
photoswitchable building block 
 
The photoswitching between open-ring and closed-ring forms of the DAET unit in the 
ideal case should provide conformational control, by either maintaining or destroying the 
secondary structure adjacent to the building block. In the studies with linear model peptides 
(Chapter 3.2.), SwI unit was shown being compatible with both principle secondary structure 
elements in peptides: the β-strand and the α-helix. The example of GS photoswitchable 
analogues (discussed in Chapter 3.4) illustrated th possibility to incorporate SwI and SwII 
into short cyclic peptide within the β-turn fold and to photomodulate range of peptide 
activities. However, gramicidin S structure is additionally stabilized via backbone 
macrocyclization. In the following example the degree of intrinsic isostery of a DAET-based 
amino acid surrogate to a β-turn fold was further explored. As well as the attempt was done to 
create a photoswitchable peptidic anticancer agent. 
As a peptide template for incorporation of the photoswitchable building block, 
peptides with reported anticancer activities were considered140. SVS-1 is one of them and was 
selected for structural reasons. This 18-residue peptide was designed to fold as a β-hairpin in 
the presence of negatively charged membrane surface (see Chapter 1.4.1.). This folding 
process was suggested to be necessary for the cytotoxicity of SVS against cancer cell lines 
and the critical role of the β-turn in adopting the amphiphilic β-sheet structure was 
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demonstrated86. Isostery of a DAET building block to the β-turn should therefore be possible 
to evaluate in a functional anticancer assay or by monitoring the folding process in the 
presence of a negatively charged membrane.  
 
 
Figure 3.26. Schematic illustration of the photocontrolled β-hairpin folding of SVS-
SwLPro(PP) by switching between β-hairpin supporting (open-ring) and disturbing (closed-
ring) forms. 
 
The designed SVS analogues should exploit the mechanism of the structural 
photoswitching schematically shown in Figure 3.26. In the flexible open-ring form of the 
DAET unit the two peptidylic β-strands should become free to interact with each other and 
should be able to form a β-hairpin, stabilized by a number of intra-strand hydrogen bonds. 
This should happened for instance in the presence of n gatively charged model membranes. 
At the same time, in the DAET closed-ring form the β-strands should become spatially 
separated through a rigid planar unit and therefore l s  the ability to fold as an amphiphilic 
secondary structure. 
Herein SwII building blocks were chosen for introduction of the photoresponsive 
functionality for the reasons discussed in Chapter 3.4.1 - higher chemical stability and 
potentially better compatibility with the β-turn geometry. The sequences were designed, as in 
the case of GS-analogues (Chapter 3.3.), by introduction of several substitutions around 
potential target place for empiric comparisons. Since molecular size approximation of a SwI 
unit in previous studies suggested rough equivalency to two to three amino acid rests, to 
further refine this estimate, both types of replacement - SwII for a dipeptide and SwII for a 
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tripeptide - were planned. The corresponding amino acid sequences are listed in Table 3.10. 
Substitution of tree amino acid rests (-DPPT-) with both diarylethene building blocks 39 and 
40 gave peptidomimetics named SVS-SwLPro(PPT) and SVS-SwDPro(PPT), respectively. 
Substitution of two proline residues (-DPP-) gave peptidomimetics named SVS-SwLPro(PP) 
and SVS-SwDPro(PP). And substitution of another tree amino acid (-VDPP-) in the β-turn 
region gave peptidomimetics named SVS-SwLPro(VPP) and SVS-SwDPro(VPP).  
 
Table 3.10. The list of synthesized SVS-1 photoswitchable analogues.  
Peptide  Sequence* 
SVS-1 KVKVKVKVPPTKVKVKVK-NH ₂ 
SVS-2 KVKVKVKVPPTKVKVKVK-NH ₂ 
SVS-SwLPro(PPT) KVKVKVKV-Sw LRro-KVKVKVK-NH ₂ 
SVS-SwDPro(PPT) KVKVKVKV-Sw DRro-KVKVKVK-NH ₂ 
SVS-SwLPro(PP) KVKVKVKV-Sw LPro-TKVKVKVK-NH ₂ 
SVS-SwDPro(PP) KVKVKVKV-Sw DPro-TKVKVKVK-NH ₂ 
SVS-SwLPro(VPP) KVKVKVK- SwLPro-TKVKVKVK-NH ₂ 
SVS-SwDPro(VPP) KVKVKVK- SwDPro-TKVKVKVK-NH ₂ 
* SwLPro denotes residue of building block 39, SwDPro – 40. 
 
3.6.1. Synthesis and purification of SVS-1 analogues 
 
Synthesis of the SVS-1 photoswitchable analogues was perform manually with Fmoc-
based SPPS technique and described in Chapter 6.2.4. Undefined side product formation was 
observed at the step of Fmoc deprotection from the amino acid coupled immediately after the 
diarylethene building blocks 39 and 40. Upon MALDI analysis the formed side products 
systematically gave masses of 18 Da less compared to the target product and this products 
remained throughout further synthesis. The side-products could be explained by a terminal 
cyclization of the N-terminus of the growing polypeptide chain that makes it inaccessible for 
the further coupling steps. In order to overcome this ermination and complete the synthesis 
convergent strategy was used141. For construction of the SVS analogues, the couplings with 
the tetrapeptides were done to overcome the problematic positions in a large step. The side 
chain protected tetrapeptides (Fmoc-K(Boc)VK(Boc)V-COOH and Fmoc-VK(Boc)VK(Boc)-
COOH) were synthesized separately and used in a single coupling cycle. In the following, 
syntheses were continued in accordance with the standard single-residue per cycle procedure. 
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As discussed in the Chapter 3.4.1. SwPro were available as racemates. However, for 
the synthesis of SVS-1 photoswitchable analogues despite use of racemic mixture the final 
products were possible to separate chromatographically. The separation of the diastereomeric 
molecules was performed in two RP-HPLC steps. In each step a different ion pairing reagent 
was employed. During first round of purification the eluents were supplemented with 0.1% of 
trifluoroacetic acid (TFA). Already at this stage both peptide isomers were separated. 
Identification which product corresponds to which enantiomeric form of the DAET proline 
was not possible on this step. This way purified products were named according to their 
HPLC retention behaviors: peptidomimetics with smaller RTs were designated with the index 
1 and their longer retaining counterparts with the index 2. The SVS analogues with the DAET 
unit in place of prolyl-prolyl-treonyl fragment were called SVS-A1 and SVS-A2; in place of 
prolyl-prolyl – SVS-B1, SVS-B2 and the remaining valyl-prolyl-prolyl substitutes – SVS-C1, 
SVS-C2. The second round of HPLC purification was done with eluents containing 0.1% of 
heptafluorobutyric acid (HFBA) – highly lipophilic ion pairing reagent. Purification of the 
wild type peptides SVS-1 and SVS-2 was performed in one round with the HFBA system. 
Notably, application of conventional eluents for peptide purification (with 5mM HCl or 0.1% 
TFA as ion-pairing agents) appeared to mask significant number of impurities which eluted at 
the same times as the target products. The SVS analogues declared as pure when being 
purified with conventional eluents, in HFBA purification appeared to have actual purities 
below 50%. This demonstrates limitations in the HPLC purity assessment when no 
precautions are done and in part may explain differences in the results obtained in this work 
and reported in the literature (see below). 
 
3.6.2. Structural analysis of SVS-1 analogues 
 
SVS-1 was reported not to have any structure in aqueous buffers and in presence of 
zwitterionic lipid vesicles (POPC) – the CD spectra at these conditions were interpreted as 
reflecting a random coil, unstructured, state86. Contrastingly, when negatively charged lipid 
vesicles (POPC/POPS, 1:1) were applied, the CD spectra showed signals with distinct 
minima in the mean residue ellipticity at 218 nm, supporting the notion that the peptide 
adopts a β-sheet fold consistent with the hairpin formation. The other peptide SVS-2, which 
contains single L-proline/D-proline mutation in the β-turn and is therefore not able to fold as 
a β-hairpin, behaved differently86. The CD spectra of SVS-2 resemble the “random coil” 
independent of the lipid charge. The ability of SVS-1 to fold into the amphiphilic hairpin in 
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response to the presence of negatively charged membrane was thus postulated to be 
responsible for selective targeting of the more negatively charged cancer cells co-present with 
the more neutral normal eukaryotic cells (see in Chapter 1.4.1.).  
An ideal photoswitchable β-turn mimetic of SVS-1 should behave in the following 
way: one of the photoforms should stabilize the β-hairpin, while the other photoform should 
be incompatible with this structure. Therefore, if the CD spectra of peptidomimetic resemble 
the signal from SVS-1, the photoswitchable unit is proven of supporting a β-hairpin, at the 
same time similarity to SVS-2 spectra will suggest the opposite. Herein CD spectra of the 
wild type peptides SVS-1 and SVS-2 as well as of SVS-1 photoswitchable analogues were 
acquired in different media including i) aqueous buffer and ii) liposomes from zwitterionic 
DMPC and iii) from negatively charged DMPC/DMPS and iv) DMPC/DMPG mixtures. The 
peptidomimetics were studied in their both photoforms using the following procedure. The 
CD spectra of the closed-ring forms were measured fi st. Next, the samples were exposed to 
visible light for time periods needed to convert 100% of the peptidomimetics into the 
colorless open-ring forms (visual control), and the second set of the CD spectra was recorded 
(see details in Chapter 6.4). The obtained CD spectra are collected in Figure 3.27 and 3.28. 
Figure 3.27 summarize CD study of the control peptides SVS-1 and SVS-2. 
According to the literature86, both peptides should be unstructured in aqueous buffers and in 
presence of zwitterionic lipids. In 10 mM phosphate buffer and with DMPC vesicles, SVS-2 
indeed showed a random coil CD signal (Figure 3.27a,b). SVS-1, surprisingly, appears being 
structured at both conditions: negative band at ca. 220 nm and a positive one at ca. 200 nm 
indicate that the peptide adopts a β-like fold. In the presence of negatively charged 
DMPC/DMPS or DMPC/DMPG liposomes, both peptides were structured (Figure 3.27c,d). 
Judging by the intensity of the 200 nm band, as expected, more molecules of SVS-1 appear to 
be folded than of SVS-2. The results directly contradict literature data for SVS-1 peptide, 
which should have been unstructured in water. Either peptide material in this work differ to 
the one used by Sinthuvanich et al. (see comment about HPLC purification in Chapter 3.6.1.) 
or other factors may play a role. For instance here a salt-free buffer was used, while the 
literature investigation was performed in presence of 150 mM NaF; here DMPC/DMPS lipid 





Figure 3.27. Circular dichroism spectra of SVS-1 and SVS-2 at 100 µg/ml concentration in 
different conditions. (a) 10 mM PB at 25°C; (b) DMPC vesicles, P:L ratio 1:50, at 40°C; (c) 
DMPC/DMPS (1:1 mol) vesicles, P:L ration 1:50, at 40°C; (d) DMPC/DMPG (3:1 mol) 
vesicles, P:L ration 1:50, at 40°C.  
 
Nevertheless, the photoswitchable SVS-1 analogues were measured in buffer solution 
and in the presence of negatively charged vesicles (DMPC/DMPG) as shown in Figure 3.28. 
In PB buffer solution all the peptidomimetics gave a CD spectra associated with a random 
coil, while in DMPC/DMPG presence appeared partially fo ded, resembling therefore general 
behavior of the SVS-2 peptide. The structures assumed by the peptidomimetics indeed 
correspond to expected β-folds. An interesting exception here was the SVS-C1 peptide – with 
membranes it shows far largest amount of the random c il signal, suggesting most of the 
peptide to remain non-bound. The non-bound fraction with this is even larger than for the 
wild type SVS-2 peptide. Difference between SVS-C1 and SVS-C2 renders the enantiomeric 
form of proline within DAET building block to play an important role in defining the peptide 
structure. This result also clearly shows that position and number of residues to be substituted 
by a DAET building block is indeed critical in the β-turn structures. When comparing 
membrane-interaction of the open-ring and closed-ring forms, both SVS-B isomers, SVS-A1 
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and SVS-C2 showed the differences in between, while CD spectra of SVS-A2 and SVS-C1 
remained almost intact. For SVS-B1 and SVS-C2 spectral differences were the largest. 
Importantly, when the differences are present, all the open-ring forms spectra resemble the 
spectrum of SVS-1, while the closed-ring forms appear similar to CD signal of SVS-2 
(Figure 3.27.d). This suggests closed-ring forms to indeed bind the membranes less and to be 
less structured, the same way as in the distorted SVS-2 peptide. 
 
 
Figure 3.28. Circular dichroism spectra of the SVS-1 photoswitchable analogues at 100 
µg/ml concentration in different conditions. Blue lines correspond to peptidomimetics in the 
open-ring forms, red – to the closed-ring forms. Solid lines correspond to spectra recorded in 
DMPC/DMPG (3:1 mol) vesicles, P:L ration 1:50, at 40°C. (a) and (b) correspond to the 
peptidomimetics SVS-A1 and SVS-A2, respectively; (c) and (d) to SVS-B1 and SVS-B2, (e) 
and (f) to SVS-C1 and SVS-C2, respectively. 
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Comparison of the degree of deviation between CD signals of the two photoforms 
(e.g. by assessing intensity at ~195 nm) across all peptide variants allows qualitative 
judgment about efficiency of the dipeptide- and tripeptide-SwII substitutions. The efficiency 
is meant here as an ability to mimic a β-turn in one photoform and to destroy the fold in the
other. Substitution of three amino acids (-DPPT-) by SwII appears to be the least effective – 
none of the peptidomimetics SVS-A1 or SVS-A2 showed any pronounced change of the CD 
lineshape during photoswitching. The same can be concluded for one of the diastereomers of 
the other tripeptidylic substitution (-VDPP- in SVS-C1). In contrast to this, the substitution of 
two amino acids (-DPP-, SVS-B peptides) achieved more effective photocontrol of the folding 
as the difference is the largest (SVS-B1) and is present in both enantiomers (compare SVS-
B2). It has to be noted that dipeptidylic substitution also gave good results in GS analogues.  
In summary: substitution of tree amino acid with DAET unit is not effective. Much better 
results showed substitution of two central amino acids (-DPP-). It was also shown the 
enantiomeric form of the proline residue in DAET building block plays an important role. 
This influence was clearly seen for pair of analogues SVS-C1 and SVS-C2. 
 
3.6.3. Antimicrobial activity of SVS analogues 
 
The antimicrobial activity for the β-hairpin forming peptide SVS-1 and its non-
foldable isomer SVS-2 was not previously reported. In the original study both peptides were 
only investigated for the anticancer cytotoxicity86. However, an antimicrobial activity was 
expected due to close similarity to canonical antimicrobial peptides – SVS peptides possess 
high positive charge and acquire amphiphilic secondary structures in membranes. In this 
work MIC assays were used to quantitatively access potential antimicrobial activities of the 
DAET-modified SVS analogues while SVS-1 and SVS-2 served control purposes. In the first 
round of experiments using only SVS wild type peptides (see Chapter 6.5. for details) 
activities against Gram-positive and Gram-negative bacteria were compared. Against Gram-
negative strains SVS-1 and SVS-2 demonstrated rather we k activity: the MIC values in 
µg/ml for E. coli were found 64, 128, and for E. faecalis 250, >250, respectively. However, 
both peptides demonstrated relatively high activity against Gram-positive bacteria strains. In 
the following study, which included the photoswitchable SVS analogues, the focus was set 
only on Gram-positive strains. Obtained MIC values are summarized in the Table 3.11. 
As was expected, SVS-1 was more active comparing to SVS-2. Against S. aureus and 
S. epidermidis MIC values for SVS-1 were higher by one- (32 against 64 µg/ml) and two- (8 
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against 32 µg/ml) dilution folds, respectively. Against S. xylosus both peptides showed equal 
MIC values (8 µg/ml). Interestingly, all photoswitchable peptidomimetics generally have 
shown equal or stronger activities than the wild types SVS-1 and SVS-2.  
The open-ring forms of peptidomimetics were designed to adopt a β-hairpin structure 
and in this way mimic the functions of peptide SVS-1 while the closed-ring forms should 
have stayed unstructured and were supposed to behave like SVS-2. This indeed was observed 
in the antimicrobial activity of peptidomimetics. For example, the analogue SVS-A1 in the 
open-ring form was more active than the closed-ring form (by two folds of dilution) against 
both S. aureus and S. epidermidis. At the same time against S. xylosus there was no difference 
observed in the MIC values for the two photoforms. Similar results were obtained for 
peptidomimetics SVS-B1, SVS-B2, SVS-C2.  
 
Table 3.11. The antimicrobial activities of SVS-1 photoswitchable analogues in both open-
ring and closed-ring forms tested against Gram-positive bacteria strains. 
 
Peptides 
MIC (µg /ml) 
S. aureus S. xylosus S. epidermidis 
Gramicidin S 4 2 2 
SVS-1 32 8 8 
SVS-2 64 8 32 
 
SVS-A1 
open-ring 16 8 4 
closed-ring 64 8 16 
 
SVS-A2 
open-ring 16 8 8 
closed-ring 32 8 8 
 
SVS-B1 
open-ring 16 8 8 
closed-ring 32 8 16 
 
SVS-B2 
open-ring 16 8 8 
closed-ring 32 8 16 
 
SVS-C1 
open-ring 32 4 8 
closed-ring 64 8 16 
 
SVS-C2 
open-ring 16 8 8 







3.6.4. Anticancer activity of SVS-1 analogues 
  
The peptide SVS-1 was reported86 to be highly active against a variety of cancer cell 
lines such as A549 (lung carcinoma), KB (epidermal carcinoma), MCF-7 (breast carcinoma), 
and MDA-MB-436 (breast carcinoma) with IC50 values around 10-20 µg/ml. At the same 
time SVS-2 was reported to be at least ten time less active with IC50 >200 µg/ml.  
In this work, cytotoxic activity assessments of SVS-1, SVS-2 were performed using 
breast cancer MCF-7 and the cervix cancer cell line HeLa (see Chapter 6.8 for details). First, 
the wild type peptides SVS-1 and SVS-2 were evaluated. In the Figure 3.28. viabilities of the 
cancer cells are expressed as a function of concentration for both of them, illustrating the 
study. SVS-1 showed IC50 values in the concentration ranges of 32-64 and of 64-128 µg/ml 
against HeLa and MCF-7 cells, respectively. SVS-2 revealed IC50 values of 64-128 and >256 
µg/ml against two cancer cell lines, respectively. In addition, the peptides were evaluated for 
their influence on the apoptosis of the HeLa cells. At the concentration 128 µg/ml both wild 
type peptides showed moderate proapoptotic action wth slightly higher activity of the SVS-1 
(Figure 3.29.). 
Obtained results contradict literature data in that SVS-1 has rather moderate 
cytotoxicity, while SVS-2 demonstrates comparable activity levels. Opposite to the 
expectations, no dramatic difference between two peptid s with different propensities for the 
β-hairpin formation was observed. 
Despite rather discouraging results above, anticancer a tivities of the photoswitchable 
SVS-1 analogues were studied. Herein cytotoxicities w re tested on two cancer cell lines: 
cervix cancer line HeLa and hepatocellular carcinoma G2. An example of concentration 
depended viability curves is shown in Figure 3.30. The IC50 values for all peptidomimetics 
are summarized in Table 3.12. In general the DAET modified peptidomimetics showed 
activities in the same concentration range as SVS-1 and SVS-2. However, neither of the 
analogues had shown any difference between the two photoforms (Table 3.12.).  
This study had shown that the peptide SVS-1 and its analogues cannot be called 
promising anticancer agents in view of their low IC50 values. Moreover, it appears that the 
cell cytotoxicity of these peptides cannot be a measure to evaluate the efficiency of β-hairpin 
folding. The two peptides SVS-1 and SVS-2 have different potency to form an amphiphilic β-





Figure 3.28. Cytotoxic activity of SVS-1 and SVS-2 measured in MTT test. (a, b) Against 




Figure 3.29. Proapoptotic action of peptides SVS-1 and SVS-2 on the cervix cancer line 





Figure 3.30. Cytotoxic activity of photoswitchable analogue SVS-B2 in both open-ring and 
closed-ring forms measured in MTT test. (a) Against cervix cancer line HeLa, (b) against 
hepatocellular carcinoma G2 cancer line. 
 
Table 3.12. Half-lethal concentrations (IC50) of photoswitchable peptidomimetics tested 
against cervix cancer line HeLa and hepatocellular carcinoma G2 (Hep G2).  
Peptide IC50 (µg
/ml) 
HeLa Hep G2 
 
SVS-A1 
open-ring 32-64 >128 
closed-ring 32-64 >128 
 
SVS-B1 
open-ring 64 128 
closed-ring 64 128 
 
SVS-B2 
open-ring 32-64 64-128 
closed-ring 32-64 64-128 
 
SVS-C1 
open-ring 32-64 >128 
closed-ring 32-64 >128 
 
SVS-C2 
open-ring 32-64 64-128 








Incorporation of molecular photoswitches into peptides or proteins should allow 
reversible control of their structure and functions by means of photoisomerization. The aim of 
this study was to explore the practical possibilities of polypeptide modification using 
photoswitchable diarylethene-based building blocks, and to investigate the effects of the 
photoinduced isomerization on the structure and functio  of several biologically active 
peptides. 
Two types of diarylethene-based building blocks suitable for incorporation into 
peptides with routine peptide synthesis were synthesized. In these units, which appear as 
amino acid surrogates, different linkers were explored to attach the amino function, including 
a hydrazide group and the backbone of another α-amino acid. These variations now render 
the photoswitchable building blocks compatible with a broad range of peptide geometries. 
The suitability of the building blocks for practical incorporation in peptides was 
successfully demonstrated on variety of linear and cyclic peptides. The range of explored 
polypeptide geometries, shown to be suitable for incorporation of the building blocks, covers 
α-helices, β-strands, β-turns, as well as the backbone of macrocycles. Physico-chemical and 
biological studies on the photoswitchable peptides allowed characterization of the building 
blocks in the context of real polypeptides in action. In particular, the efficiencies of 
photoisomerization, the general hydrophobicities, and the degree of conformational flexibility 
were characterized, as well as the absorption and fluorescence properties of the units. The 
general requirements were identified for selecting a target polypeptide sequences that can be 
successfully modified by the building blocks. A prototype of a reversibly photocontrolled 
fluorescent label was demonstrated, based on the diarylethene photoswitchable moiety. 
With the novel photoswitchable analogues of Gramicidin S and SVS, respectively, 
major and minor conformational changes of the polypeptide backbone upon 
photoisomerization were demonstrated. The previously reported strong anticancer activity of 
the SVS peptide was disproved. Gramicidin S, on the other hand, was shown to possess 
anticancer cytotoxicity. For the first time with a diarylethene photoswitchable unit in a 
peptide backbone, a functional photodynamic control was achieved for a peptide. The range 
of peptidomimetics allowed photoisomerization-mediated photocontrol of the antimicrobial, 






Durch Einbau lichtabhängiger Schalter kann die Struktur und Funktion von Peptiden 
und Proteinen durch Photoumwandlung gezielt gesteuert werden. Ziel dieser Studie war es, 
Diarylethen-Bausteine, die sich durch Licht umwandel  lassen, zur Modifikation von 
Peptiden und Proteinen einzusetzen, und die Auswirkung der lichtinduzierten Umwandlung 
auf die Struktur und Funktion verschiedener biologisch aktiver Peptide zu untersuchen.  
Hierbei wurden zwei verschiedene Diarylethen-Bausteine ntwickelt, die sich für den 
Einbau in Polypeptide mittels Standard-Peptidsynthese ignen. Für diese Bausteine wurden 
verschiedene funktionelle Gruppen, wie z.B. Hydrazin oder Aminosäure-Analoga, getestet, 
durch die ein Einbau in Peptide anstelle von normalen Aminosäuren möglich ist. Durch 
Verwendung verschiedener funktioneller Gruppen wird ein Einbau dieser durch Licht 
umwandelbaren Bausteine in unterschiedlichste Peptidstrukturen gewährleistet. Die Eignung 
dieser Bausteine für verschiedene Peptidkonformationen konnte durch den Einbau in Peptide 
mit α-helikaler, β-Faltblatt und Schleife sowie in zyklischen Peptiden erfolgreich gezeigt 
werden. Durch Einbau der photoschaltbaren Module in bekannte Peptide konnten diese 
Bausteine unter realen Bedingungen getestet werden. Hi rbei konnte die Effizienz der durch 
Licht induzierten Umwandlung, die Hydrophobizität, der Grad der strukturellen Flexibilität, 
sowie die Absorption und Fluoreszenzeigenschaften di ser Bausteine charakterisiert werden. 
Außerdem wurden die grundlegende Voraussetzungen für die Auswahl der Zielsequenzen 
identifiziert, und es wurde der Prototyp eines revesibel umwandelbaren 
Fluoreszenzfarbstoffes gezeigt.  
Anhand neuer Analoga von Gramicidin S und SVS konnte  verschiedene Licht-
induzierte Strukturänderungen des Peptidrückgrats gezei t werden. Die kürzlich postulierte 
anti-Krebs Wirkung des SVS Peptides konnte widerlegt werden, wohingegen für Gramicidin 
S eine cytotoxische Wirkung gegen Krebszellen nachgewiesen werden konnte. Mit dieser 
Arbeit gelang es das erste Mal, ein durch Licht kontrollierbares Peptid basierend auf 
Diarylethen-Bausteinen herzustellen, dessen antimikrob elle, hämolytische und anti-Krebs 





6. Experimental part 
 
All starting materials were purchased from Merck, Acros, ABCR, Fisher, Iris Biotech, 
and Biosolve. Tetrahydrofuran, N,N-diisopropylethylamine, and diethyl ether were freshly 
distilled under a nitrogen atmosphere from sodium/benzophenone, and toluene was distilled 
from sodium. Analytical reversed-phase high-performance liquid chromatography (RP-
HPLC) was done on Jasco system. Next columns were used: Vydac® C18 column (4.6 mm x 
250 mm), flow rate 1.5 ml/min for analytical analysis, Vydac® C18 column (10 mm x 250 
mm), flow rate 7 ml/min for semi-preparative purification, Vydac® C18 column (22 mm x 
250 mm), flow rate 17 ml/min for preparative purification; solvent A: 90% water, 10% 
acetonitrile, solvent B: 10% water, 90% acetonitrile; 5mM hydrochlotic acid, or 0.1% 
trifluoroacetic acid, or 0.1% heptafluorobutyric acid were used as an ion-pairing agents. For 
preparative HPLC individual gradients were optimized for each peptide depending on a 
retention time of the target peptide and type of contaminations; for analytical and 
semipreparative HPLC typical gradient slopes were 1% and 4% B per min, respectively. 1H 
and 13C NMR spectra were recorded on Bruker Avance 300 spectrometer and referenced to 
TMS. 
Mass spectra were recorded either on an Agilent 1100 LC/MSD SL instrument by 
chemical ionization (CI), or on a Bruker Autoflex III by matrix-assisted laser induced 
desorption/ionization (MALDI). MALDI samples were co-crystallized with a matrix of 3,5-
dihydroxy-benzoic acid or α-cyano-4-hydroxycinnamic acid from acidic H2O/MeCN 
solutions on a stainless steel target. 
For UV illumination either standard UV lamp Spectroline® from Spectronics 
Corporation (model with the unfiltered short wave tube (UV-C, 254 nm)), or the model XX-
15Fe, equipped with two integrally filtered 15-Watt tubes (BLE-1T155) were used. The latter 
provides peak UV intensity of 1100 µW/cm² at 25 cm. For fluorescent microscopy in cell 
cultures were used Axioskop 40 with filter set 09 (λex 450‑490 nm, λemm 515 nm), Carl Zeiss, 
Jena, Germany. 
Compound 8a and 33 were synthesized according to ref. 27. The fluorine label 3-
(trifluoromethyl)bicyclopent-[1.1.1]-1-yl glycine (CF3-Bpg) was provided by Prof. Komarov 






6.1. General organic synthesis 
 
4-(2-(5-(2-(((9H-fluoren-9-yl)methoxy)carbonyl)hydrazine-1-carbonyl)-2-
methylthiophen-3-yl)cyclopent-1-en-1-yl)-5-methylthiophene-2-carboxylic acid, 31. 
 
Compound 8a (5 g, 14.3 mmol) was dissolved in 
dimethylformamide (25 ml). N,N-diisopropylcarbodiimde 
(DIC, 1.76 g, 14 mmol) and subsequently DIPEA (3.7 g, 
28.6 mmol) were added to the solution. Fmoc-hydrazine 
(Fmoc-NH-NH2; 3.56 g; 14 mmol) was added immediately.  After stirring the reaction 
mixture overnight, it was poured into water (100 ml). The precipitate was filtered, dissolved 
in dichloromethane (200 ml) and washed twice with 0.5 M aq solution of sodium bicarbonate 
(100 ml), then with 0.5 M aq solution of hydrochloric acid (100 ml), in order to remove the 
unreacted compound 8a. The organic phase was dried over magnesium sulfate. Evaporation 
of dichloromethane under reduced pressure gave the crude material which contained, along 
with the desirable 31, also the by-product 32. The by-product did not interfere with the solid-
phase peptide synthesis, so the obtained material was used without additional purification. 
The analytically pure 31 was obtained using RP-HPLC (H2O/MeCN mixture as the eluent). 
Compound 31: 1H-NMR (300 MHz, DMSO-d6), δ = 1.88 (s, 3H, CH3), 1.91 (s, 3H, CH3), 
2.02 (m, 2H, 2CH2), 2.78 (t, 4H, 2CH2), 4.13-4.42 (CH2CH, two rotamers 4:1), 7.11-7.92 (m, 
aromatic protons, 10Н), 9.01 and 9.36 (rotamers 1:4, 1Н), 10.22 and 10.46 (rotamers 4:1, 
1Н), 12.89 (broad singlet, 1H). 13C-NMR (300 MHz, DMSO-d6), δ = 14.1, 14.4, 22.2, 46.4, 
66.1, 120.1, 125.2, 127.1, 127.7, 129.8, 130.4, 132.9, 133.9, 134.2, 136.2, 136.3, 140.0, 
140.7, 141.7, 143.6, 156.3, 160.7, 162.6. Compound 41: 1H-NMR (300 MHz, DMSO-d6), δ = 
1.89 (m, 6H), 2.05 (m, 2H), 2.78 (t, 4H, 2CH2), 4.14-4.41 (CH2CH, 6H), 7.12-7.92 (m, 
aromatic protons, 18H), 9.00 and 9.36 (rotamers 1:3, 2H), 10.23 and 10.47 (rotamers 3:1, 
2H). 13C-NMR (300 MHz, DMSO-d6), δ = 14.2, 22.2, 38.1, 46.5, 66.1, 120.1, 125.2, 127.1, 











15 g of compound 33 (0.0456 mol) were dissolved in 250 ml of 
dried tetrahydrofuran under inert argon atmosphere. Th  solution was 
cooled to -78 0C using bath with dry ice. 20 ml (0.051 mol) of the 2.5 
M butyllithium solution in hexane were added to thecooled solution. 
The reaction mixture was let go to the temperature -10 0C and was cooled again to - 78 0C.  4 
g (0.0548 mol) of the dimethylformamide were added to the solution at -78 0C. The solution 
was slowly (during half an hour) heated to 0 0C and stirred at room temperature for one hour. 
Then the reacting mixture was poured into 200 ml of water and 55 ml (0.055 mol) of 1 M 
hydrochloric acid were added. The product 34 was extracted with 200 ml of diethyl ether. 
Separated organic phase was dried over anhydrous magnesium sulfate and volatile solvents 
were removed under reduced pressure. 15 g of obtained crude material were used in further 
synthetic steps without purification. Compound 34: 1H-NMR (300 MHz, CDCl3), δ = 1.85 (s, 
3H, CH3), 1.92 (s, 3H, CH3), 2.00 (m, 2H, CH2), 2.74 (t, 4H, 2CH2), 6.59 (s, 1H, CH), 7.75 





15 g of crude compound 34 (approximately 0.0456 mol) 
were dissolved in 250 ml of toluene. 7.1 g (0.0684 mol) of 2,2-
dimethyl-1,3-propanediol and 0.1 g of p-toluenesulfonic acid 
were added. The solution was refluxed with Dean-Stark 
apparatus until all the water formed in reaction was removed (0.82 g). Toluene was removed 
under reduced pressure. Pure product 35 was obtained after column chromatography on silica 
gel with hexane/ethyl acetate 10:1 mixture used as the eluent. The yield in two steps from 33 
to 35 was 14.2 g (76 % of theoretical). Compound 35: 1H-NMR (300 MHz, CDCl3), δ = 1.27 
(s, 6H, 2CH3),1.84 (s, 3H, CH3), 1.91 (s, 3H, CH3), 2.00 (m, 2H, CH2), 2.72 (t, 4H, 2CH2), 







3 g (0.00733 mol) of compound 35 were dissolved in 50 ml 
of dried tetrahydrofuran under inert argon atmosphere. The solution 
was cooled to - 78 0C by cooling bath with dry ice. To the cooled 
solution were added 3.52 ml (0.0088 mol) of the 2.5 M butyllithium 
solution in hexane. The reaction mixture was let go to the 
temperature -10 0C and then again was cooled to – 78 0C.  2.27 g (0.0088 mol) of the 
compound 36 (tert-butyl (S)-2-(methoxy(methyl)carbamoyl)pyrrolidine-1-carboxylate) were 
dissolved in 10 ml of dried tetrahydrofuran and added to the cooled solution. The solution 
was slowly (during half an hour) heated to 0 0C and stirred at room temperature for one hour. 
The reaction mixture was poured into 100 ml of water and 9 ml (0.009 mol) of 1 M 
hydrochloric acid were added. The product 37 was extracted with 100 ml of diethyl ether. The 
separated organic phase was dried over anhydrous magnesium sulfate and volatile solvents 
were removed under reduced pressure. Pure product 37 was obtained after column 
chromatography on silica gel with hexane/ethyl acette 5:1 mixture used as the eluent. The 
obtained yield was 3.1 g (73 % of theoretical). Comp und 37: 1H-NMR (300 MHz, CDCl3), δ 
= 1.27 (s, 9H, 3CH3), 1.89 (m, 3H), 2.01-208 (rotamer, m, 6H, 2CH3), 2.12 (m, 2H, CH2), 
2.23 (m, 1H, CH), 2.84 (t, 4H, 2CH2), 3.45-3.56 (rotamer, m, 2H), 4.70-4.94 (rotamer, m, 
1H), 7.40-7.47 (rotamer, two singlets, 2H, 2CH), 9.73-9.75 (rotamer, s, 1H, CHO). 
 
4-(2-(5-((tert-butoxycarbonyl)-L-prolyl)-2-methylthiophen-3-yl)cyclopent-1-en-1-yl)-5-
methylthiophene-2-carboxylic acid, 38. 
 
3.1 g (0.0064 mol) of compound 37 were dissolved in 40 
ml of ethanol. 7.42 g (0.032 mol) of freshly prepared silver oxide 
and 0.5 g (0.0128 mol) sodium hydroxide were added an
vigorously stirred for two hours. 20 ml (0.02 mol) of 1 M 
hydrochloric acid and 40 ml of ethanol were added. Formed 
precipitate was filtered through a paper filter and the product 38 was extracted twice with 100 
ml of diethyl ether from the obtained filtrate. Separated organic phases were combined and 
dried over anhydrous magnesium sulfate. Volatile solvents were removed under reduced 
pressure. The yield was 3.2 g (100% of theoretical) of pure compound 38. Compound 38: 1H-
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NMR (300 MHz, CDCl3), δ = 1.28 (s, 9H, 3CH3), 1.89 (m, 3H), 1.96-2.01 (rotamer, s, 3H, 
CH3), 2.06-2.07 (rotamer, s, 3H, CH3), 2.10 (m, 2H, CH2), 2.23 (m, 1H, CH), 2.81 (m, 4H, 
2CH2), 3.46-3.56 (rotamer, m, 2H), 4.71-4.95 (rotamer, m, 1H), 7.39-7.45 (rotamer, s, 1H, 
CH), 7.59-7.60 (rotamer, s, 1H, CH). 
 
4-(2-(5-((((9H-fluoren-9-yl)methoxy)carbonyl)-L-prolyl)-2-methylthiophen-3-
yl)cyclopent-1-en-1-yl)-5-methylthiophene-2-carboxylic acid, 39. 
 
 3.2 g (0.0064 mol) of compound 38 were dissolved in 20 
ml of dichloromethane. 2 ml of trifluoroacetic acid were added to 
the solution and it was kept afterwards for 2 hours at room 
temperature. The volatile solvents were removed under reduced 
pressure. The obtained yellow oil was dissolved in 50 ml of 
water/acetone 1:1 mixture and 1,075 g (0.0128 mol) of sodium bicarbonate and 3.3 g (0.0128 
mol) of fluorenylmethoxycarbonyl chloride (FmocCl) were added. The solution was actively 
stirred for 4 hours at room temperature. 12.8 ml (0.0128) of 1 M hydrochloric acid were 
slowly added and the product 39 was extracted twice with 100 ml of diethyl ether. Separated 
organic phases were combined and dried over anhydrous magnesium sulfate and volatile 
solvents were removed under reduced pressure. Pure compound 39 was obtained after 
column chromatography on silica gel with hexane/ethyl acetate 5:1 mixture used as the 
eluent. The obtained yield was 4 g (91 % of theoretical). Compound 39: 1H-NMR (300 MHz, 
CDCl3), δ = 1.92 (m, 3H), 1.97-2.03 (rotamer, s, 3H, CH3), 2.10 (s, 3H, CH3), 2.12 (m, 2H, 
CH2), 2.25 (m, 1H, CH), 2.82 (m, 4H, 2CH2), 3.61-3.74 (rotamer, m, 2H), 4.08-4.43 (rotamer, 
m, 3H, CH2CH) 4.86-5.05 (rotamer, m, 1H), 7.14-7.79 (m, aromatic protons, 10Н). 
 
4-(2-(5-((((9H-fluoren-9-yl)methoxy)carbonyl)-D-prolyl)-2-methylthiophen-3-
yl)cyclopent-1-en-1-yl)-5-methylthiophene-2-carboxylic acid, 40. 
 
  Compound 40 was synthesized likewise compound 39
with the difference that precursor 35 was treated with D-proline 
N-Boc protected Weinreb amide (tert-butyl (R)-2-
(methoxy(methyl)carbamoyl)pyrrolidine-1-carboxylate) instead 
of compound 36. Compound 40: 1H-NMR (300 MHz, CDCl3), δ 
= 1.92 (m, 3H), 1.97-2.03 (rotamer, s, 3H, CH3), 2.10 (s, 3H, CH3), 2.12 (m, 2H, CH2), 2.25 
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(m, 1H, CH), 2.82 (m, 4H, 2CH2), 3.61-3.74 (rotamer, m, 2H), 4.08-4.43 (rotamer, m, 3H, 
CH2CH) 4.86-5.05 (rotamer, m, 1H), 7.14-7.79 (m, aromatic protons, 10Н).  
 
6.2. Synthesis of peptides containing SwI and Sw II  
 
6.2.1. Synthesis of β/α-model peptide and its 19F-labeled analogues  
 
Standard Fmoc-based solid-phase peptide synthesis (SPPS) and commercially 
available reagents were used for the peptide synthesis. Leucine pre-loaded Rink amide 
MBHA resin with loading 0.67 mmol/g (150 mg, 1 equiv) was used. Coupling of the amino 
acids was performed using the following molar ratios of the reagents: Fmoc-amino acid (4 
equiv), HOBt (4 equiv), HBTU (3.9 equiv), DIPEA (8 equiv). Incorporation of the 
diarylethene building block SwI was performed by coupling with 31 (in the crude mixture; 
the amount was taken to provide 1.5 equiv), HOBt (1.5 equiv), PyBOP (1.5 equiv), DIPEA (3 
equiv). The coupling time in all cases was 40 min. N-Fmoc deprotection was carried out by 
treating the resin with 20% piperidine in DMF for 20 min. After completing the synthesis, the 
resin was washed with dichloromethane and dried under vacuum for 24 h. The peptides were 
cleaved from the resin with cleavage cocktail (trifluoroacetic acid, triisopropylsilane and 
water, 92.5:2.5:5 v/v mixture, 10 ml, 30 min).  The volatile products from the filtered solution 
were blown off by a flow of argon. The residual material was dissolved in an acetonitrile-
water (1:1) mixture and lyophilized. The crude peptidomimetics in open-ring form were 
purified on a preparative C18 column with a linear A:B gradient of 5% B/min. The purity of 
the peptidomimetics was checked on the analytical C18 column with a linear A:B gradient of 
1% B/min. The identity of each peptidomimetic was confirmed by MALDI-TOF mass 
spectrometry; m/z = 2618.5 [β/α-model peptide], 2696.5 [β2I/α-, β4I/α-, β8I/α-, β/α3L-, 
β/α7I-, β/α8L-, β/α11L-model peptides], 2738.5 [β6A/α-model peptide], 2662.5 [β/α4F-
model peptide], 2646.5 [β/α10Y-model peptide]. 
 
6.2.2. Synthesis of α/α-model peptide and its 19F-labeled analogues 
 
Labeled fragments of peptide BP100 was synthesized as escribe in Chapter 6.2.1 to 
the point of Fmoc deprotection after coupling of the 12th amino acid. Further, the resin was 
treated for two hours with the mixture of next reagnts: building block 8a (0.5 equiv), HOBt 
(0.5 equiv), PyBOP (0.5 equiv), DIPEA (1 equiv). After the reaction was completed, the resin 
90 
 
was washed with dichloromethane and dried under vacuum for 24 h. The peptidomimetics 
were cleaved and purified as describe in Chapter 6.2.1. The identity of each peptidomimetic 
was confirmed by MALDI-TOF mass spectrometry; m/z = 3151 [α/α-model peptide], 3311 
[α/α-3L-, α/α-7I-, α/α-8L-model peptides], 3242 [α/α-4F-model peptide], 3210 [α/α-10Y-
model peptide]. 
 
6.2.3. Syntheses of GS analogues containing SwI 
 
Standard SPPS was used for the peptide synthesis. D-phenylalanine pre-loaded 2-
chlorotrityl resin with loading 0.70 mmol/g (143 mg, 1 equiv) was used. Coupling of the 
amino acids and incorporation of the building block SwI was performed as describe in 
Chapter 6.2.1. After completing the synthesis, the resin was washed with dichloromethane 
and dried under vacuum for 24 h. The linear precursors were cleaved from the resin with 
maintaining side chain protecting groups with a mixture of hexafluoroisopropanol and 
dichloromethane (1:3, 10 ml, 5 min). The volatile products from the filtered solution were 
blown off by a flow of argon. After dissolving the r sidual material in an acetonitrile-water 
(1:1) mixture, and subsequent lyophilization, the crude linear precursors were obtained and 
used for the cyclization without further purification. The conversion of the linear precursors 
into the targeted cyclic peptidomimetics was done in dichloromethane (1 L, the precursors 
did not dissolve completely) with the solution of PyBOP (3 equiv) and HOBt (3 equiv) in 
DMF (2 ml), followed by adding DIPEA (6 equiv) to the suspension of the corresponding 
precursor. The reaction mixture was stirred for 8 h, and additional amount (the same as 
above) of the coupling reagents (PyBOP, HOBt, DIPEA) was added. After 16 h, the solvent 
was evaporated under reduced pressure and the residual material was lyophilized. The 
deprotection cocktail (trifluoroacetic acid, triisopr pylsilane and water, 92.5:2.5:5 v/v, 10 ml) 
was added. After 15 min, the volatiles were blown off by flow of argon and the residual oil 
was lyophilized. The crude cyclic peptides in the open-ring form were purified in two steps 
using RP-HPLC: on a first step with a preparative column with a linear A:B gradient of 8% 
B/min followed by a second step on a semi-preparative column with a linear A:B gradient of 
4% B/min. The purity of the peptides was checked on the analytical column with a linear A:B 
gradient of 1% B/min. The identity of each peptidomimetic was confirmed by MALDI mass 




6.2.4. Syntheses of GS analogues containing SwII  
 
Synthesis of GS analogues containing building blocks 39 and 40 was performed as 
describe in Chapter 3.4.1. The crude cyclic peptides in the open-ring form were purified 
using RP-HPLC on a preparative column with a linear A:B gradient of 2% B/min. The purity 
of the peptides was checked on the analytical column with a linear A:B gradient of 1% 
B/min. The identity of each peptidomimetic was confirmed by MALDI mass spectrometry; 
m/z = 1280,5 [GS-SwLPro(FP), GS-SwDPro(FP)]. 
 
6.2.5. Syntheses of SVS-1 analogues containing SwII  
 
Standard SPPS was used for the peptide synthesis. Lysine pre-loaded 2-chlorotrityl 
resin with loading 0.70 mmol/g (143 mg, 1 equiv) was used. The synthesis was carried out 
manually. The coupling of the amino acids was performed using the same mixture as describe 
in Chapter 6.2.1. In cases of lysine and threonine introduction, double coupling was 
performed since not completed reaction was observed aft r single coupling. The amino acid 
sequences were grown to the place of the diarylethen  building block incorporation, which 
then was introduced following the procedure describe in Chapter 6.2.1. To overcome the side-
product formation on the step of Fmoc deprotection of the next amino acid after building 
blocks SwII was coupled a tetrapeptide fragment with protected side chains and N-terminus. 
For SVS-1 A- and B-type analogues were used tetrapeptide Fmoc-K(Boc)VK(Boc)V-COOH. 
For C-type was used Fmoc-VK(Boc)VK(Boc)-COOH tetrapeptide. The corresponding 
tetrapeptides were synthesized on chlorotrityl resin and then cleaved with 
hexafluoroisopropanol and lyophilized. Couplings of the tetrapeptides were performed using 
the following molar ratios of the reagents: Fmoc-tetrapeptide (2 equiv), HOBt (2 equiv), 
PyBOP (2 equiv), DIPEA (4 equiv). The coupling process was monitored with RP-HPLC and 
normally was completed after 24 hours. After attaching of the tetrapeptide fragments, the 
sequences were completed with standard protocol (Chapter 6.2.1). Separation (in case of 
racemic mixture of building blocks 39 and 40) and purification of the peptides was done on 
preparative column in two steps: first, with the eluent containing 0.1% of trifluoroacetic acid 
as ion pairing reagent, second, with the eluent conaini g 0.1% of heptafluorobutyric acid. In 
both cases a linear A:B gradient of 4% B/min was used. The purity of the peptides was 
checked with the analytical C18 column with a linear A:B gradient of 1% B/min. The identity 
of each peptide was confirmed by MALDI-TOF mass spectrometry; m/z = 2031.7 [SVS-1, 
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SVS-2], 2119.7 [SVS-SwLPro(PPT), SVS-SwDPro(PPT)], 2220.7 [SVS-SwLPro(PP), SVS-
SwDPro(PP)], 2121.7 [SVS-SwLPro(VPP), SVS-SwDPro(VPP)]. 
 
6.3. Solid-state 19F-NMR measurements 
 
All oriented samples were prepared at peptide to lipid ration 1:100 in 1,2-dimyristoyl-
sn-glycero-3-phosphocholine (DMPC). 0.206 µmol of peptide (0.54 mg – 0.68 mg) and 20.6 
µmol of lipid (14 mg) were dissolved in methanol and spread over 14 glass plates (18 x 7.5 
mm, Marienfeld Laboratory Glassware). For the samples with the peptides in closed-ring 
form method was modified: first, the peptides was dissolved in methanol and the solutions 
was exposed to UV light for 15 min. Then the needed amount of lipid was added and the 
mixture was spread over the glass plates. The spread solvent was allowed to dry out for 40 
min and after that the glass plates were dried in vacuum for 8 hours. The plates were stacked 
and hydrated in chambers with saturated potassium sulfate (96% relative humidity) for 12 
hours and wrapped in Nescofilm® and Sarogold® films. Between the measurements the 
samples were stored at -20°C. 
In order to check the sample quality and degree of lipid orientation 31P NMR 
measurements were done at 202.5 MHz on an Avance III Bruker NMR spectrometer (Bruker 
Biospin, Karlsruhe, Germany) with a wide bore 500 MHz magnet. Standard flat-coil double-
resonance 1H/X probe from Bruker was used. As a pulse sequence wer  used a Hahn echo 
with a 90° pulse of 5 µs and a 30 µs echo time with 1H SPINAL64 decoupling during 
acquisition142,143. The acquisition time was 10 ms and the recycle time 1 s. Typically 128 
scans were acquired.  
Solid-state 19F-NMR experiments were performed using double-tuned goniometer-
equipped 19F/1H probes from Doty Scientific (Columbia, USA) at a frequency of 470.6 MHz 
using an anti-ringing sequence with a 90° pulse of 3.25 µs, a sweep width of 500 kHz, 4096 
data points, and proton decoupling using TPPM144,145. The 19F chemical shift was referenced 
using the fluorine signal of a 100 mM solution of NaF, of which the chemical shift was set to 




6.4. Circular dichroism measurements 
 
CD spectra were recorded on Jasco J-815 Spectrophotometer between 400 and 180 
nm at 0.1 nm intervals, using 1 mm Suprasil® quartz glass cuvettes (Hellma) at 25°C. Three 
consecutive scans at a scan-rate of 10 nm/min, 8 s response time and 1 nm bandwidth were 
averaged each for the sample and for the background spectra. After subtraction of the 
appropriate background spectra, the corrected CD data were processed using Jasco Spectra 
Analysis software. 
The phosphate buffer (PB) was of 20 mM concentration and pH 7.2 (at 30°C). For all 
measured peptides were prepared their stock solutions in 50% ethanol (1000 µg/ml) with RP-
HPLC concentration correction. The needed amounts of material were sampled into 2 ml 
glass vials and the solvent was dried in vacuum. The stock solutions and all samples of 
peptides in closed-ring form were kept in dark.  
The lipid vesicles were prepared accordingly to following protocol: the lipids (DMPC 
and DMPG) stock solution was prepared at concentration 10 mg/ml in methanol/chloroform 
1:1 mixture, and aliquoted in 2 ml glass vials to supply with 0.4 mg of either pure DMPC or 
mixture of DMPC/DMPG 3:1. The solvents were removed by a flow of argon and the vials 
were dried under vacuum for 8 hours. 300 µl of the PB was added to vials and the mixture 
was vortexed for 10 min. Then 10 times freeze-thaw cycle was repeated. The resulting 
mixture was sonicated for 30 min at 40°C. To the glass vials with sample peptides were 
added 100 µl of the PB, sonicated for 5 min, followed by adding the suspension of vesicles 
(300 µl) prepared as describe above to yield 400 µl volume in each case. The resulting 
samples have lipid concentration 1 mg/ml and peptid to lipid ratio 1:50.  
 
6.5. Antimicrobial activity assays 
 
The antimicrobial activities of peptides were measured using a stepwise microdilution 
assay according to standard protocols with some modifications146,147. Wild type peptides and 
their analogues in open-ring and closed-ring forms were dissolved in 50% ethanol to give 
stock solutions with concentrations 512 µg/ml. Sterile flat-bottom polystyrene, non-tissue 
culture-treated, 96-well microtiter plates (Nunc™) were used for the assay. First, 50 µl of the 
double concentrated Mueller-Hinton (MH) medium (Mast Diagnostika, Reinfeld, Germany) 
were filled to the initial row. Next, 50 µl of the non-concentrated MH medium were applied 
to the remaining test wells, for the positive (without peptides), and the negative (sterility) 
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controls. Addition of the peptide stock solutions (50 µl) to the wells of the initial raw 
provided the starting peptide concentration for the gradient. For construction of the gradient 
all subsequent rows were filled by transfer of 50 µl aliquots from the preceding rows. From 
the last row of wells 50 µl aliquots were discarded. Bacterial suspensions were prepared from 
the culture in the exponential growth phase, which was diluted first to the OD550 = 0.2 and 
then 1:100 in order to inoculate each well with 5×105 CFU/ml, excluding the negative 
control. To examine bacterial growth, the plates were incubated for 22 hours at 37°C without 
agitation. Then, 20 µl of an aqueous 0.2 mg/ml solution of the redox indicator resazurin (7-
hydroxy-3H-phenoxazin-3-one-10-oxide) were added to each well. The plates were incubated 
for another 2 hours at 37°C, and the redox status of resazurin was determined 
spectrophotometrically using a microplate reader FLASHScan 550 (Jena Analytic, Germany). 
The difference in absorbance of resorufin at 570 nm and resazurin at 600 nm was used to 
assess bacterial growth and thereby to determine the lowest concentrations that inhibit 
bacterial growth (Minimum Inhibitory Concentration, MIC). Both Gram-positive and Gram-
negative bacteria strains were used (E.coli DSM 1103, S. typhimurium, B. Subtilis, aureus 
DSM 1104, Staphylococcus epidermidis DSM 1798 and Staphylococcus xylosus DSM 20267). 
 
6.6. Visualization of antimicrobial activity  
 
The plate-pouring technique was used to find out the optimal light exposition length 
and concentration of the inactive peptidomimetic GS-SwI(FP) that would show a distinct 
photoswitching effect.  The desired amount of peptidomimetic was added to a 17 ml aliquot 
of melted LB-Miller agar that had been cooled to 60°C. To obtain a uniform bacterial lawn, 
the medium was at the same time inoculated with 100 µl exponentially growing bacterial 
culture diluted to a suspension with an OD550 of 0.2. This mixture was poured into a Petri 
dish. Once the medium was solidified, each of these prepared plates was exposed to visible 
light through holes in a cardboard mask for a discrete period of time. The geometrical shapes 
were cut out from black paper covering the entire Petri dish, such that the photoswitchable 
compound was converted into the open-ring form only i  the areas exposed to light. The 




6.7. Hemolytic activity assays 
 
To test the hemolytic activities of peptides and their analogues, human erythrocytes 
(RBC) were used. RBC concentrates in 10 % citrate-phos hate-dextrose medium were 
obtained from Karlsruhe municipal hospital. The cells were washed twice in Tris-HCl buffer 
(HB, 310 mOs/ml, pH 7.6) by centrifugation at 300×g, 4°C. The final pellet was diluted 200-
fold in HB and incubated for 5 min at 37°C before it was added to the solutions of the 
peptides. These solutions were prepared as a two-fold dilution series of 200 µl aliquots in the 
same buffer in 1.5 ml Eppendorf™ tubes. The hemolysis reaction was initiated by the 
addition of 200 µl RBC suspension. The samples were incubated under periodic agitation for 
30 min at 37°C, after which their content was centrifuged for 10 min at 13000×g. The 
absorption of the supernatant at 540 nm gives the ext nt of hemolysis, with 0% taken from 
the peptide-free control, and 100% after treatment with 0.1% Triton X-100. To make sure that 
this step did not interfere with the analysis, the samples with GS analogous in the closed-ring 
forms were back-converted to their open-ring colorless forms by 30 min exposure to visible 
light before absorption measurements. 
 
6.8. Anticancer assays 
 
Experiments were carried out at the Institute of Biology of Taras Shevchenko National 
University of Kyiv. The following cell lines were used in the study: the cervix cancer line 
HeLa, the breast cancer line MCF-7, hepatocellular carcinoma G2 cancer line. 
The cytotoxic effect of peptides was evaluated in MTT-colorimetric test as percent of 
live cells related to control and characterized by IC50 index
148,149. For the MTT assay 
performing 96 well plates were used. As a culture media, DMEM («Sigma», USA) with 10 % 
FBS («Sigma»), 2 mM L-glutamine, and 40 µg/ml gentamicin were used. Cells were plated 
with starting concentration about 5x104 cells/ml in the sample volume of 100 µl in each of 96 
well. After a 24 hours period of plated cells adaptation in normal conditions (5 % CO2, 100 
humidity, 37°C), the peptides were added (in 100 µl of media). For each tested peptide at 
least two rows of repetition and 5 or 11 two-fold diluted concentrations were used. After the 
24 hours period of incubation, to the medium in each well 10µl of MTT solution was added 
and the plates were left for 4 hours preincubation. The medium from each well was removed 




The number of living cells was determined using MTT-colorimetric test, cell counts 
were performed using a tripan blue dye after 24 h incubation with peptides. 
The cell distribution in different phases of the cell ycle was assessed by a flow cytometry150. 
Cells were plated in 6-well plates at the density 5x104 cells/ml in total volume 5 ml of the 
complete culture medium. The cells were then incubated with a peptide for 48 h under normal 
conditions. The proportions of cells in different phases of the cell cycle were measured by 
flow cytometry with argon laser (λex = 488 nm, λem = 585/40 nm) («Becton Dickinson», 
USA) following standard staining. The samples were analyzed with the help of the Mod Fit 
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